Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Peter Valent

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Anatomy

Chemicals & Drugs

Physiology

Histamine Release

Disorders

Living Beings

Pollen

Procedures

Immunophenotyping

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Boehm Alexandra; Mayerhofer Matthias; Herndlhofer Susanne; Knoebl Paul; Sillaber Christian; Sperr Wolfgang R; Jaeger Ulrich; Valent Peter
Evaluation of in vivo antineoplastic effects of rapamycin in patients with chemotherapy-refractory AML.
Sillaber C; Herrmann H; Bennett K; Rix U; Baumgartner C; Böhm A; Herndlhofer S; Tschachler E; Superti-Furga G; Jäger U; Valent P
Immunosuppression and atypical infections in CML patients treated with dasatinib at 140 mg daily.
Valent P; Sperr W R; Födinger M; Kundi M
Comorbidity, iron overload and HFE variants: a new prognostic complex in MDS?

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Peter Valent (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Boehm Alexandra; Mayerhofer Matthias; Herndlhofer Susanne; Knoebl Paul; Sillaber Christian; Sperr Wolfgang R; Jaeger Ulrich; Valent Peter
Evaluation of in vivo antineoplastic effects of rapamycin in patients with chemotherapy-refractory AML.
European journal of internal medicine 2009;20(8):775-8.
2009: Sillaber C; Herrmann H; Bennett K; Rix U; Baumgartner C; Böhm A; Herndlhofer S; Tschachler E; Superti-Furga G; Jäger U; Valent P
Immunosuppression and atypical infections in CML patients treated with dasatinib at 140 mg daily.
European journal of clinical investigation 2009;39(12):1098-109.
2009: Valent P; Sperr W R; Födinger M; Kundi M
Comorbidity, iron overload and HFE variants: a new prognostic complex in MDS?
European journal of clinical investigation 2009;39(12):1112-3.
2009: Krauth M-T; Mirkina I; Herrmann H; Baumgartner C; Kneidinger M; Valent P
Midostaurin (PKC412) inhibits immunoglobulin E-dependent activation and mediator release in human blood basophils and mast cells.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2009;39(11):1711-20.
2009: Sperr W R; El-Samahi A; Kundi M; Girschikofsky M; Winkler S; Lutz D; Endler G; Rumpold H; Agis H; Sillaber C; Jäger U; Valent P
Elevated tryptase levels selectively cluster in myeloid neoplasms: a novel diagnostic approach and screen marker in clinical haematology.
European journal of clinical investigation 2009;39(10):914-23.
2009: Gleixner K V; Mayerhofer M; Vales A; Gruze A; Hörmann G; Cerny-Reiterer S; Lackner E; Hadzijusufovic E; Herrmann H; Iyer A K; Krauth M-T; Pickl W F; Marian B; Panzer-Grümayer R; Sillaber C; Maeda H; Zielinski C; Valent P
Targeting of Hsp32 in solid tumors and leukemias: a novel approach to optimize anticancer therapy.
Current cancer drug targets 2009;9(5):675-89.
2009: Valent P; Horny H-P
Minimal diagnostic criteria for myelodysplastic syndromes and separation from ICUS and IDUS: update and open questions.
European journal of clinical investigation 2009;39(7):548-53.
2009: Valent Peter
Pathogenesis, classification, and therapy of eosinophilia and eosinophil disorders.
Blood reviews 2009;23(4):157-65.
2009: Valent Peter; Hofmann Wolf-Karsten; Büsche Guntram; Sotlar Karl; Horny Hans-Peter; Haase Detlef; Haferlach Torsten; Kern Wolfgang; Bettelheim Peter; Baumgartner Christian; Sperr Wolfgang R; Nösslinger Thomas; Wimazal Friedrich; Giagounidis Aristoteles A; Lübbert Michael; Krieger Otto; Kolb Hans-Jochem; Stauder Reinhard; Pfeilstöcker Michael; Gattermann Norbert; Fonatsch Christa; Aul Carlo; Germing Ulrich
Meeting report: Vienna 2008 Workshop of the German-Austrian Working Group for Studying Prognostic Factors in Myelodysplastic Syndromes.
Annals of hematology 2009;88(7):607-11.
2009: Edlmayr Johanna; Niespodziana Katarzyna; Linhart Birgit; Focke-Tejkl Margarete; Westritschnig Kerstin; Scheiblhofer Sandra; Stoecklinger Angelika; Kneidinger Michael; Valent Peter; Campana Raffaela; Thalhamer Josef; Popow-Kraupp Theresia; Valenta Rudolf
A combination vaccine for allergy and rhinovirus infections based on rhinovirus-derived surface protein VP1 and a nonallergenic peptide of the major timothy grass pollen allergen Phl p 1.
Journal of immunology (Baltimore, Md. : 1950) 2009;182(10):6298-306.
2009: Böhm A; Aichberger K J; Mayerhofer M; Herrmann H; Florian S; Krauth M-T; Derdak S; Samorapoompichit P; Sonneck K; Vales A; Gleixner K V; Pickl W F; Sperr W R; Valent P
Targeting of mTOR is associated with decreased growth and decreased VEGF expression in acute myeloid leukaemia cells.
European journal of clinical investigation 2009;39(5):395-405.
2009: Wimazal F; Nösslinger T; Baumgartner C; Sperr W R; Pfeilstöcker M; Valent P
Deferasirox induces regression of iron overload in patients with myelodysplastic syndromes.
European journal of clinical investigation 2009;39(5):406-11.
2009: Lupinek Christian; Roux Kenneth H; Laffer Sylvia; Rauter Ingrid; Reginald Kavita; Kneidinger Michael; Blatt Katharina; Ball Tanja; Pree Ines; Jahn-Schmid Beatrice; Allam Jean-Pierre; Novak Natalija; Drescher Anja; Kricek Franz; Valent Peter; Englund Hakan; Valenta Rudolf
Trimolecular complex formation of IgE, Fc(epsilon)RI, and a recombinant nonanaphylactic single-chain antibody fragment with high affinity for IgE.
Journal of immunology (Baltimore, Md. : 1950) 2009;182(8):4817-29.
2009: Ball T; Linhart B; Sonneck K; Blatt K; Herrmann H; Valent P; Stoecklinger A; Lupinek C; Thalhamer J; Fedorov A A; Almo S C; Valenta R
Reducing allergenicity by altering allergen fold: a mosaic protein of Phl p 1 for allergy vaccination.
Allergy 2009;64(4):569-80.
2009: Valent Peter; Wieser Rotraud
Update on genetic and molecular markers associated with myelodysplastic syndromes.
Leukemia & lymphoma 2009;50(3):341-8.
2009: Gangl K; Reininger R; Bernhard D; Campana R; Pree I; Reisinger J; Kneidinger M; Kundi M; Dolznig H; Thurnher D; Valent P; Chen K-W; Vrtala S; Spitzauer S; Valenta R; Niederberger V
Cigarette smoke facilitates allergen penetration across respiratory epithelium.
Allergy 2009;64(3):398-405.
2009: Remsing Rix L L; Rix U; Colinge J; Hantschel O; Bennett K L; Stranzl T; Müller A; Baumgartner C; Valent P; Augustin M; Till J H; Superti-Furga G
Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009;23(3):477-85.
2009: Valent Peter
Interleukin-33: a regulator of basophils.
Blood 2009;113(7):1396-7.
2008: Boehm A; Sperr W R; Leitner G; Worel N; Oehler L; Jaeger E; Mitterbauer M; Haas O A; Valent P; Kalhs P; Rabitsch W
Comorbidity predicts survival in myelodysplastic syndromes or secondary acute myeloid leukaemia after allogeneic stem cell transplantation.
European journal of clinical investigation 2008;38(12):945-52.
2008: Zebedin Eva; Simma Olivia; Schuster Christian; Putz Eva Maria; Fajmann Sabine; Warsch Wolfgang; Eckelhart Eva; Stoiber Dagmar; Weisz Eva; Schmid Johannes A; Pickl Winfried F; Baumgartner Christian; Valent Peter; Piekorz Roland P; Freissmuth Michael; Sexl Veronika
Leukemic challenge unmasks a requirement for PI3Kdelta in NK cell-mediated tumor surveillance.
Blood 2008;112(12):4655-64.
2008: Aichberger K J; Sperr W R; Gleixner K V; Kretschmer A; Valent P
Treatment responses to cladribine and dasatinib in rapidly progressing aggressive mastocytosis.
European journal of clinical investigation 2008;38(11):869-73.
2008: Platzbecker Uwe; Bornhäuser Martin; Germing Ulrich; Stumpf Julian; Scott Bart L; Kröger Nicolaus; Schwerdtfeger Rainer; Böhm Alexandra; Kobbe Guido; Theuser Catrin; Rabitsch Werner; Valent Peter; Sorror Mohamed L; Ehninger Gerhard; Deeg H Joachim
Red blood cell transfusion dependence and outcome after allogeneic peripheral blood stem cell transplantation in patients with de novo myelodysplastic syndrome (MDS).
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(11):1217-25.
2008: Hadzijusufovic Emir; Rebuzzi Laura; Gleixner Karoline V; Ferenc Veronika; Peter Barbara; Kondo Rudin; Gruze Alexander; Kneidinger Michael; Krauth Maria-Theresa; Mayerhofer Matthias; Samorapoompichit Puchit; Greish Khaled; Iyer Arun K; Pickl Winfried F; Maeda Hiroshi; Willmann Michael; Valent Peter
Targeting of heat-shock protein 32/heme oxygenase-1 in canine mastocytoma cells is associated with reduced growth and induction of apoptosis.
Experimental hematology 2008;36(11):1461-70.
2008: Krauth Maria-Theresa; Binder Thomas; Ohler Leopold; Jäger Ulrich; Valent Peter
Improvement of cardiac function, mitral regurgitation and pulmonary hypertension in a patient with chronic eosinophilic leukemia (CEL) after low dose imatinib therapy.
Leukemia research 2008;32(11):1779-83.
2008: Hantschel Oliver; Gstoettenbauer Agnes; Colinge Jacques; Kaupe Ines; Bilban Martin; Burkard Thomas R; Valent Peter; Superti-Furga Giulio
The chemokine interleukin-8 and the surface activation protein CD69 are markers for Bcr-Abl activity in chronic myeloid leukemia.
Molecular oncology 2008;2(3):272-81.
2008: Hauswirth A W; Escribano L; Prados A; Nuñez R; Mirkina I; Kneidinger M; Florian S; Sonneck K; Vales A; Schernthaner G-H; Sanchez-Muñoz L; Sperr W R; Bühring H-J; Orfao A; Valent P
CD203c is overexpressed on neoplastic mast cells in systemic mastocytosis and is upregulated upon IgE receptor cross-linking.
International journal of immunopathology and pharmacology 2008;21(4):797-806.
2008: Stauder Reinhard; Nösslinger Thomas; Pfeilstöcker Michael; Sperr Wolfgang R; Wimazal Friedrich; Krieger Otto; Valent Peter
Impact of age and comorbidity in myelodysplastic syndromes.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6(9):927-34.
2008: Mothes-Luksch Nadine; Stumvoll Sabine; Linhart Birgit; Focke Margit; Krauth Marie-Therese; Hauswirth Alexander; Valent Peter; Verdino Petra; Pavkov Tea; Keller Walter; Grote Monika; Valenta Rudolf
Disruption of allergenic activity of the major grass pollen allergen Phl p 2 by reassembly as a mosaic protein.
Journal of immunology (Baltimore, Md. : 1950) 2008;181(7):4864-73.
2008: Baumgartner Christian; Gleixner Karoline V; Peter Barbara; Ferenc Veronika; Gruze Alexander; Remsing Rix Lily L; Bennett Keiryn L; Samorapoompichit Puchit; Lee Francis Y; Pickl Winfried F; Esterbauer Harald; Sillaber Christian; Superti-Furga Giulio; Valent Peter
Dasatinib inhibits the growth and survival of neoplastic human eosinophils (EOL-1) through targeting of FIP1L1-PDGFRalpha.
Experimental hematology 2008;36(10):1244-53.
2008: Harir Noria; Boudot Cédric; Friedbichler Katrin; Sonneck Karoline; Kondo Rudin; Martin-Lannerée Séverine; Kenner Lukas; Kerenyi Marc; Yahiaoui Saliha; Gouilleux-Gruart Valérie; Gondry Jean; Bénit Laurence; Dusanter-Fourt Isabelle; Lassoued Kaïss; Valent Peter; Moriggl Richard; Gouilleux Fabrice
Oncogenic Kit controls neoplastic mast cell growth through a Stat5/PI3-kinase signaling cascade.
Blood 2008;112(6):2463-73.
2008: Valent Peter
Low erythropoietin production as non-oncogenic co-factor contributing to disease-manifestation in low-risk MDS: a hypothesis supported by unique case reports.
Leukemia research 2008;32(9):1333-7.
2008: Wappl M; Jaeger E; Streubel B; Gisslinger H; Schwarzinger I; Valent P; Oehler L
Dasatinib inhibits progenitor cell proliferation from polycythaemia vera.
European journal of clinical investigation 2008;38(8):578-84.
2008: Linhart Birgit; Mothes-Luksch Nadine; Vrtala Susanne; Kneidinger Michael; Valent Peter; Valenta Rudolf
A hypoallergenic hybrid molecule with increased immunogenicity consisting of derivatives of the major grass pollen allergens, Phl p 2 and Phl p 6.
Biological chemistry 2008;389(7):925-33.
2008: Valent Peter
Emerging stem cell concepts for imatinib-resistant chronic myeloid leukaemia: implications for the biology, management, and therapy of the disease.
British journal of haematology 2008;142(3):361-78.
2008: Hauswirth Alexander W; Födinger Manuela; Fritz Marika; Müllauer Leonhard; Simonitsch-Klupp Ingrid; Streubel Berthold; Chott Andreas; Sperr Wolfgang R; Jäger Ulrich; Valent Peter
Indolent systemic mastocytosis associated with atypical small lymphocytic lymphoma: a rare form of concomitant lymphoproliferative disease.
Human pathology 2008;39(6):917-24.
2008: Weghofer M; Dall'Antonia Y; Grote M; Stöcklinger A; Kneidinger M; Balic N; Krauth M-T; Fernández-Caldas E; Thomas W R; van Hage M; Vieths S; Spitzauer S; Horak F; Svergun D I; Konarev P V; Valent P; Thalhamer J; Keller W; Valenta R; Vrtala S
Characterization of Der p 21, a new important allergen derived from the gut of house dust mites.
Allergy 2008;63(6):758-67.
2008: Wimazal F; Baumgartner C; Sonneck K; Zauner C; Geissler P; Schur S; Samorapoompichit P; Müllauer L; Födinger M; Agis H; Sperr W R; Valent P
Mixed-lineage eosinophil/basophil crisis in MDS: a rare form of progression.
European journal of clinical investigation 2008;38(6):447-55.
2008: Laffer S; Lupinek C; Rauter I; Kneidinger M; Drescher A; Jordan J-H; Krauth M-T; Valent P; Kricek F; Spitzauer S; Englund H; Valenta R
A high-affinity monoclonal anti-IgE antibody for depletion of IgE and IgE-bearing cells.
Allergy 2008;63(6):695-702.
2008: Mittermann Irene; Reininger Renate; Zimmermann Maya; Gangl Katharina; Reisinger Jürgen; Aichberger Karl J; Greisenegger Elli K; Niederberger Verena; Seipelt Joachim; Bohle Barbara; Kopp Tamara; Akdis Cezmi A; Spitzauer Susanne; Valent Peter; Valenta Rudolf
The IgE-reactive autoantigen Hom s 2 induces damage of respiratory epithelial cells and keratinocytes via induction of IFN-gamma.
The Journal of investigative dermatology 2008;128(6):1451-9.
2008: Baumgartner C; Sonneck K; Krauth M-T; Kneidinger M; Födinger M; Hauswirth A W; Müllauer L; Valent P
Immunohistochemical assessment of CD25 is equally sensitive and diagnostic in mastocytosis compared to flow cytometry.
European journal of clinical investigation 2008;38(5):326-35.
2008: Chen Kuan-Wei; Fuchs Gudrun; Sonneck Karoline; Gieras Anna; Swoboda Ines; Douladiris Nikolas; Linhart Birgit; Jankovic Marija; Pavkov Tea; Keller Walter; Papadopoulos Nikolaos G; Valent Peter; Valenta Rudolf; Vrtala Susanne
Reduction of the in vivo allergenicity of Der p 2, the major house-dust mite allergen, by genetic engineering.
Molecular immunology 2008;45(9):2486-98.
2008: Wimazal F; Sperr W R; Kundi M; Vales A; Fonatsch C; Thalhammer-Scherrer R; Schwarzinger I; Valent P
Prognostic significance of serial determinations of lactate dehydrogenase (LDH) in the follow-up of patients with myelodysplastic syndromes.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(5):970-6.
2008: Valent Peter; Agis Hermine; Sperr Wolfgang; Sillaber Christian; Horny Hans-Peter
Diagnostic and prognostic value of new biochemical and immunohistochemical parameters in chronic myeloid leukemia.
Leukemia & lymphoma 2008;49(4):635-8.
2008: Valent Peter; Deininger Michael
Clinical perspectives of concepts on neoplastic stem cells and stem cell-resistance in chronic myeloid leukemia.
Leukemia & lymphoma 2008;49(4):604-9.
2008: Mayerhofer Matthias; Gleixner Karoline V; Hoelbl Andrea; Florian Stefan; Hoermann Gregor; Aichberger Karl J; Bilban Martin; Esterbauer Harald; Krauth Maria-Theresa; Sperr Wolfgang R; Longley Jack B; Kralovics Robert; Moriggl Richard; Zappulla Jacques; Liblau Roland S; Schwarzinger Ilse; Sexl Veronika; Sillaber Christian; Valent Peter
Unique effects of KIT D816V in BaF3 cells: induction of cluster formation, histamine synthesis, and early mast cell differentiation antigens.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(8):5466-76.
2008: Haas Katja; Kundi Michael; Sperr Wolfgang R; Esterbauer Harald; Ludwig Wolf-Dieter; Ratei Richard; Koller Elisabeth; Gruener Helga; Sauerland Cristina; Fonatsch Christa; Valent Peter; Wieser Rotraud
Expression and prognostic significance of different mRNA 5'-end variants of the oncogene EVI1 in 266 patients with de novo AML: EVI1 and MDS1/EVI1 overexpression both predict short remission duration.
Genes, chromosomes & cancer 2008;47(4):288-98.
2008: Hauswirth Alexander W; Skrabs Cathrin; Schützinger Christian; Raderer Markus; Chott Andreas; Valent Peter; Lechner Klaus; Jäger Ulrich
Autoimmune thrombocytopenia in non-Hodgkin's lymphomas.
Haematologica 2008;93(3):447-50.
2008: Valent P; Krieger O; Stauder R; Wimazal F; Nösslinger T; Sperr W R; Sill H; Bettelheim P; Pfeilstöcker M
Iron overload in myelodysplastic syndromes (MDS) - diagnosis, management, and response criteria: a proposal of the Austrian MDS platform.
European journal of clinical investigation 2008;38(3):143-9.
2008: Kastl Stefan P; Speidl Walter S; Kaun Christoph; Katsaros Katharina M; Rega Gersina; Afonyushkin Taras; Bochkov Valery N; Valent Peter; Assadian Afshin; Hagmueller Georg W; Hoeth Martina; de Martin Rainer; Ma Yongsheng; Maurer Gerald; Huber Kurt; Wojta Johann
In human macrophages the complement component C5a induces the expression of oncostatin M via AP-1 activation.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(3):498-503.
2008: Kneidinger Michael; Schmidt Uwe; Rix Uwe; Gleixner Karoline V; Vales Anja; Baumgartner Christian; Lupinek Christian; Weghofer Margit; Bennett Keiryn L; Herrmann Harald; Schebesta Alexandra; Thomas Wayne R; Vrtala Susanne; Valenta Rudolf; Lee Francis Y; Ellmeier Wilfried; Superti-Furga Giulio; Valent Peter
The effects of dasatinib on IgE receptor-dependent activation and histamine release in human basophils.
Blood 2008;111(6):3097-107.
2008: Mayerhofer Matthias; Gleixner Karoline V; Mayerhofer Julia; Hoermann Gregor; Jaeger Eva; Aichberger Karl J; Ott Rene G; Greish Khaled; Nakamura Hideaki; Derdak Sophia; Samorapoompichit Puchit; Pickl Winfried F; Sexl Veronika; Esterbauer Harald; Schwarzinger Ilse; Sillaber Christian; Maeda Hiroshi; Valent Peter
Targeting of heat shock protein 32 (Hsp32)/heme oxygenase-1 (HO-1) in leukemic cells in chronic myeloid leukemia: a novel approach to overcome resistance against imatinib.
Blood 2008;111(4):2200-10.
2008: Sonneck K; Baumgartner C; Rebuzzi L; Marth K; Chen K W; Hauswirth A W; Florian S; Vrtala S; Bühring H J; Valenta R; Valent P
Recombinant allergens promote expression of aminopeptidase-n (CD13) on basophils in allergic patients.
International journal of immunopathology and pharmacology 2008;21(1):11-21.
2008: Sillaber C; Mayerhofer M; Böhm A; Vales A; Gruze A; Aichberger K J; Esterbauer H; Pfeilstöcker M; Sperr W R; Pickl W F; Haas O A; Valent P
Evaluation of antileukaemic effects of rapamycin in patients with imatinib-resistant chronic myeloid leukaemia.
European journal of clinical investigation 2008;38(1):43-52.
2008: Sotlar Karl; Bache Anja; Stellmacher Florian; Bültmann Burkhard; Valent Peter; Horny Hans-Peter
Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a [corrected] clonal hematological non-mast [corrected] cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F.
The Journal of molecular diagnostics : JMD 2008;10(1):58-66.
2008: Rauter Ingrid; Krauth Maria-Theresa; Westritschnig Kerstin; Horak Friedrich; Flicker Sabine; Gieras Anna; Repa Andreas; Balic Nadja; Spitzauer Susanne; Huss-Marp Johannes; Brockow Knut; Darsow Ulf; Behrendt Heidrun; Ring Johannes; Kricek Franz; Valent Peter; Valenta Rudolf
Mast cell-derived proteases control allergic inflammation through cleavage of IgE.
The Journal of allergy and clinical immunology 2008;121(1):197-202.
2008: Stauder Reinhard; Wimazal Friedrich; Nösslinger Thomas; Krieger Otto; Sperr Wolfgang R; Sill Heinz; Pfeilstöcker Michael; Valent Peter
[Individualized management and therapy of myelodysplastic syndromes.]
Wiener klinische Wochenschrift 2008;120(17-18):523-37.
2008: Weghofer Margit; Grote Monika; Dall'Antonia Yuliya; Fernández-Caldas Enrique; Krauth Maria-Theresa; van Hage Marianne; Horak Friedrich; Thomas Wayne R; Valent Peter; Keller Walter; Valenta Rudolf; Vrtala Susanne
Characterization of folded recombinant Der p 5, a potential diagnostic marker allergen for house dust mite allergy.
International archives of allergy and immunology 2008;147(2):101-9.
2008: Valent Peter; Lechner Klaus
Diagnosis and treatment of autoimmune haemolytic anaemias in adults: a clinical review.
Wiener klinische Wochenschrift 2008;120(5-6):136-51.
2008: Valent Peter
Systemic mastocytosis.
Cancer treatment and research 2008;142():399-419.
2007: Valent Peter
Imatinib-resistant chronic myeloid leukemia (CML): Current concepts on pathogenesis and new emerging pharmacologic approaches.
Biologics : targets & therapy 2007;1(4):433-48.
2007: Krauth M T; Födinger M; Rebuzzi L; Greul R; Chott A; Valent P
Aggressive systemic mastocytosis with sarcoma-like growth in the skeleton, leukemic progression, and partial loss of mast cell differentiation antigens.
Haematologica 2007;92(12):e126-9.
2007: Westritschnig Kerstin; Linhart Birgit; Focke-Tejkl Margarete; Pavkov Tea; Keller Walter; Ball Tanja; Mari Adriano; Hartl Arnulf; Stöcklinger Angelika; Scheiblhofer Sandra; Thalhamer Josef; Ferreira Fatima; Vieths Stefan; Vogel Lothar; Böhm Alexandra; Valent Peter; Valenta Rudolf
A hypoallergenic vaccine obtained by tail-to-head restructuring of timothy grass pollen profilin, Phl p 12, for the treatment of cross-sensitization to profilin.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(11):7624-34.
2007: Haase Detlef; Germing Ulrich; Schanz Julie; Pfeilstöcker Michael; Nösslinger Thomas; Hildebrandt Barbara; Kundgen Andrea; Lübbert Michael; Kunzmann Regina; Giagounidis Aristoteles A N; Aul Carlo; Trümper Lorenz; Krieger Otto; Stauder Reinhard; Müller Thomas H; Wimazal Friedrich; Valent Peter; Fonatsch Christa; Steidl Christian
New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients.
Blood 2007;110(13):4385-95.
2007: Wöhrer S; Rabitsch W; Shehata M; Kondo R; Esterbauer H; Streubel B; Sillaber C; Raderer M; Jaeger U; Zielinski C; Valent P
Mesenchymal stem cells in patients with chronic myelogenous leukaemia or bi-phenotypic Ph+ acute leukaemia are not related to the leukaemic clone.
Anticancer research 2007;27(6B):3837-41.
2007: Gleixner Karoline V; Mayerhofer Matthias; Sonneck Karoline; Gruze Alexander; Samorapoompichit Puchit; Baumgartner Christian; Lee Francis Y; Aichberger Karl J; Manley Paul W; Fabbro Doriano; Pickl Winfried F; Sillaber Christian; Valent Peter
Synergistic growth-inhibitory effects of two tyrosine kinase inhibitors, dasatinib and PKC412, on neoplastic mast cells expressing the D816V-mutated oncogenic variant of KIT.
Haematologica 2007;92(11):1451-9.
2007: Sperr Wolfgang; Valent Peter
Biology and clinical features of myeloid neoplasms with inv(3)(q21q26) or t(3;3)(q21q26).
Leukemia & lymphoma 2007;48(11):2096-7.
2007: Agis H; Sperr W R; Herndlhofer S; Semper H; Pirc-Danoewinata H; Haas O A; Mannhalter C; Esterbauer H; Geissler K; Sillaber C; Jäger U; Valent P
Clinical and prognostic significance of histamine monitoring in patients with CML during treatment with imatinib (STI571).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(11):1834-41.
2007: Wimazal Friedrich; Fonatsch Christa; Thalhammer Renate; Schwarzinger Ilse; Müllauer Leonhard; Sperr Wolfgang R; Bennett John M; Valent Peter
Idiopathic cytopenia of undetermined significance (ICUS) versus low risk MDS: the diagnostic interface.
Leukemia research 2007;31(11):1461-8.
2007: Vales Anja; Kondo Rudin; Aichberger Karl J; Mayerhofer Matthias; Kainz Birgit; Sperr Wolfgang R; Sillaber Christian; Jäger Ulrich; Valent Peter
Myeloid leukemias express a broad spectrum of VEGF receptors including neuropilin-1 (NRP-1) and NRP-2.
Leukemia & lymphoma 2007;48(10):1997-2007.
2007: Pfeilstöcker Michael; Karlic Heidrun; Nösslinger Thomas; Sperr Wolfgang; Stauder Reinhard; Krieger Otto; Valent Peter
Myelodysplastic syndromes, aging, and age: correlations, common mechanisms, and clinical implications.
Leukemia & lymphoma 2007;48(10):1900-9.
2007: Aichberger K J; Herndlhofer S; Agis H; Sperr W R; Esterbauer H; Rabitsch W; Knöbl P; Haas O A; Thalhammer R; Schwarzinger I; Sillaber C; Jäger U; Valent P
Liposomal cytarabine for treatment of myeloid central nervous system relapse in chronic myeloid leukaemia occurring during imatinib therapy.
European journal of clinical investigation 2007;37(10):808-13.
2007: Schulenburg A; Cech P; Herbacek I; Marian B; Wrba F; Valent P; Ulrich-Pur H
CD44-positive colorectal adenoma cells express the potential stem cell markers musashi antigen (msi1) and ephrin B2 receptor (EphB2).
The Journal of pathology 2007;213(2):152-60.
2007: Gleixner Karoline V; Rebuzzi Laura; Mayerhofer Matthias; Gruze Alexander; Hadzijusufovic Emir; Sonneck Karoline; Vales Anja; Kneidinger Michael; Samorapoompichit Puchit; Thaiwong Tuddow; Pickl Winfried F; Yuzbasiyan-Gurkan Vilma; Sillaber Christian; Willmann Michael; Valent Peter
Synergistic antiproliferative effects of KIT tyrosine kinase inhibitors on neoplastic canine mast cells.
Experimental hematology 2007;35(10):1510-21.
2007: Thallinger Christiane; Werzowa Johannes; Poeppl Wolfgang; Kovar Florian M; Pratscher Barbara; Valent Peter; Quehenberger Peter; Joukhadar Christian
Comparison of a treatment strategy combining CCI-779 plus DTIC versus DTIC monotreatment in human melanoma in SCID mice.
The Journal of investigative dermatology 2007;127(10):2411-7.
2007: Vrtala Susanne; Focke Margarete; Kopec Jolanta; Verdino Petra; Hartl Arnulf; Sperr Wolfgang R; Fedorov Alexander A; Ball Tanja; Almo Steve; Valent Peter; Thalhamer Josef; Keller Walter; Valenta Rudolf
Genetic engineering of the major timothy grass pollen allergen, Phl p 6, to reduce allergenic activity and preserve immunogenicity.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(3):1730-9.
2007: Mayerhofer M; Aichberger K J; Florian S; Valent P
Recognition sites for microbes and components of the immune system on human mast cells: relationship to CD antigens and implications for host defense.
International journal of immunopathology and pharmacology 2007;20(3):421-34.
2007: Böhm Alexandra; Födinger Manuela; Wimazal Friedrich; Haas Oskar A; Mayerhofer Matthias; Sperr Wolfgang R; Esterbauer Harald; Valent Peter
Eosinophilia in systemic mastocytosis: clinical and molecular correlates and prognostic significance.
The Journal of allergy and clinical immunology 2007;120(1):192-9.
2007: Kondo Rudin; Gleixner Karoline V; Mayerhofer Matthias; Vales Anja; Gruze Alexander; Samorapoompichit Puchit; Greish Khaled; Krauth Maria-Theresa; Aichberger Karl J; Pickl Winfried F; Esterbauer Harald; Sillaber Christian; Maeda Hiroshi; Valent Peter
Identification of heat shock protein 32 (Hsp32) as a novel survival factor and therapeutic target in neoplastic mast cells.
Blood 2007;110(2):661-9.
2007: Valent P; Akin C; Escribano L; Födinger M; Hartmann K; Brockow K; Castells M; Sperr W R; Kluin-Nelemans H C; Hamdy N A T; Lortholary O; Robyn J; van Doormaal J; Sotlar K; Hauswirth A W; Arock M; Hermine O; Hellmann A; Triggiani M; Niedoszytko M; Schwartz L B; Orfao A; Horny H-P; Metcalfe D D
Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria.
European journal of clinical investigation 2007;37(6):435-53.
2007: Valent Peter; Horny Hans-Peter; Bennett John M; Fonatsch Christa; Germing Ulrich; Greenberg Peter; Haferlach Torsten; Haase Detlef; Kolb Hans-Jochen; Krieger Otto; Loken Michael; van de Loosdrecht Arjan; Ogata Kiyoyuki; Orfao Alberto; Pfeilstöcker Michael; Rüter Björn; Sperr Wolfgang R; Stauder Reinhard; Wells Denise A
Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference.
Leukemia research 2007;31(6):727-36.
2007: Swoboda Ines; Bugajska-Schretter Agnes; Linhart Birgit; Verdino Petra; Keller Walter; Schulmeister Ulrike; Sperr Wolfgang R; Valent Peter; Peltre Gabriel; Quirce Santiago; Douladiris Nikolaos; Papadopoulos Nikolaos G; Valenta Rudolf; Spitzauer Susanne
A recombinant hypoallergenic parvalbumin mutant for immunotherapy of IgE-mediated fish allergy.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(10):6290-6.
2007: Hauswirth A W; Sonneck K; Florian S; Krauth M T; Bohm A; Sperr W R; Valenta R; Schernthaner G H; Printz D; Fritsch G; Buhring H J; Valent P
Interleukin-3 promotes the expression of E-NPP3/CD203C on human blood basophils in healthy subjects and in patients with birch pollen allergy.
International journal of immunopathology and pharmacology 2007;20(2):267-78.
2007: Niederberger Verena; Reisinger Jürgen; Valent Peter; Krauth Maria-Theresa; Pauli Gabrielle; van Hage Marianne; Cromwell Oliver; Horak Friedrich; Valenta Rudolf
Vaccination with genetically modified birch pollen allergens: immune and clinical effects on oral allergy syndrome.
The Journal of allergy and clinical immunology 2007;119(4):1013-6.
2007: Aichberger Karl J; Mayerhofer Matthias; Gleixner Karoline V; Krauth Maria-Theresa; Gruze Alexander; Pickl Winfried F; Wacheck Volker; Selzer Edgar; Müllauer Leonhard; Agis Hermine; Sillaber Christian; Valent Peter
Identification of MCL1 as a novel target in neoplastic mast cells in systemic mastocytosis: inhibition of mast cell survival by MCL1 antisense oligonucleotides and synergism with PKC412.
Blood 2007;109(7):3031-41.
2007: Rebuzzi Laura; Willmann Michael; Sonneck Karoline; Gleixner Karoline V; Florian Stefan; Kondo Rudin; Mayerhofer Matthias; Vales Anja; Gruze Alexander; Pickl Winfried F; Thalhammer Johann G; Valent Peter
Detection of vascular endothelial growth factor (VEGF) and VEGF receptors Flt-1 and KDR in canine mastocytoma cells.
Veterinary immunology and immunopathology 2007;115(3-4):320-33.
2007: Krauth Maria-Theresa; Böhm Alexandra; Agis Hermine; Sonneck Karoline; Samorapoompichit Puchit; Florian Stefan; Sotlar Karl; Valent Peter
Effects of the CD33-targeted drug gemtuzumab ozogamicin (Mylotarg) on growth and mediator secretion in human mast cells and blood basophils.
Experimental hematology 2007;35(1):108-16.
2007: Hauswirth A W; Florian S; Printz D; Sotlar K; Krauth M-T; Fritsch G; Schernthaner G-H; Wacheck V; Selzer E; Sperr W R; Valent P
Expression of the target receptor CD33 in CD34+/CD38-/CD123+ AML stem cells.
European journal of clinical investigation 2007;37(1):73-82.
2007: Thallinger C; Poeppl W; Pratscher B; Mayerhofer M; Valent P; Tappeiner G; Joukhadar C
CCI-779 plus cisplatin is highly effective against human melanoma in a SCID mouse xenotranplantation model.
Pharmacology 2007;79(4):207-13.
2007: Sonneck Karoline; Florian Stefan; Müllauer Leonhard; Wimazal Friedrich; Födinger Manuela; Sperr Wolfgang R; Valent Peter
Diagnostic and subdiagnostic accumulation of mast cells in the bone marrow of patients with anaphylaxis: Monoclonal mast cell activation syndrome.
International archives of allergy and immunology 2007;142(2):158-64.
2007: Niederberger Verena; Ring Johannes; Rakoski Jürgen; Jager Siegfried; Spitzauer Susanne; Valent Peter; Horak Friedrich; Kundi Michael; Valenta Rudolf
Antigens drive memory IgE responses in human allergy via the nasal mucosa.
International archives of allergy and immunology 2007;142(2):133-44.
2006: Schulenburg Axel; Ulrich-Pur Herbert; Thurnher Dietmar; Erovic Boban; Florian Stefan; Sperr Wolfgang R; Kalhs Peter; Marian Brigitte; Wrba Friedrich; Zielinski Christoph C; Valent Peter
Neoplastic stem cells: a novel therapeutic target in clinical oncology.
Cancer 2006;107(10):2512-20.
2006: Aichberger Karl J; Mayerhofer Matthias; Vales Anja; Krauth Maria-Theresa; Gleixner Karoline V; Bilban Martin; Esterbauer Harald; Sonneck Karoline; Florian Stefan; Derdak Sophia; Pickl Winfried F; Agis Hermine; Falus Andras; Sillaber Christian; Valent Peter
The CML-related oncoprotein BCR/ABL induces expression of histidine decarboxylase (HDC) and the synthesis of histamine in leukemic cells.
Blood 2006;108(10):3538-47.
2006: Valent Peter
Use of interleukin-11 to stimulate platelet production in myelodysplastic syndromes.
Leukemia & lymphoma 2006;47(10):1999-2001.
2006: Eiwegger T; Rigby N; Mondoulet L; Bernard H; Krauth M-T; Boehm A; Dehlink E; Valent P; Wal J M; Mills E N C; Szépfalusi Z
Gastro-duodenal digestion products of the major peanut allergen Ara h 1 retain an allergenic potential.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2006;36(10):1281-8.
2006: Florian S; Sonneck K; Czerny M; Hennersdorf F; Hauswirth A W; Bühring H-J; Valent P
Detection of novel leukocyte differentiation antigens on basophils and mast cells by HLDA8 antibodies.
Allergy 2006;61(9):1054-62.
2006: Florian Stefan; Esterbauer Harald; Binder Thomas; Müllauer Leonhard; Haas Oskar A; Sperr Wolfgang R; Sillaber Christian; Valent Peter
Systemic mastocytosis (SM) associated with chronic eosinophilic leukemia (SM-CEL): detection of FIP1L1/PDGFRalpha, classification by WHO criteria, and response to therapy with imatinib.
Leukemia research 2006;30(9):1201-5.
2006: Valent Peter
Diagnostic evaluation and classification of mastocytosis.
Immunology and allergy clinics of North America 2006;26(3):515-34.
2006: Kastl S P; Speidl W S; Kaun C; Rega G; Assadian A; Weiss T W; Valent P; Hagmueller G W; Maurer G; Huber K; Wojta J
The complement component C5a induces the expression of plasminogen activator inhibitor-1 in human macrophages via NF-kappaB activation.
Journal of thrombosis and haemostasis : JTH 2006;4(8):1790-7.
2006: Sotlar K; Saeger W; Stellmacher F; Stahmer J; Jäckle S; Valent P; Horny H-P
"Occult" mastocytosis with activating c-kit point mutation evolving into systemic mastocytosis associated with plasma cell myeloma and secondary amyloidosis.
Journal of clinical pathology 2006;59(8):875-8.
2006: Flicker Sabine; Steinberger Peter; Ball Tanja; Krauth Maria-Theresa; Verdino Petra; Valent Peter; Almo Steve; Valenta Rudolf
Spatial clustering of the IgE epitopes on the major timothy grass pollen allergen Phl p 1: importance for allergenic activity.
The Journal of allergy and clinical immunology 2006;117(6):1336-43.
2006: Agis H; Jaeger E; Doninger B; Sillaber C; Marosi C; Drach J; Schwarzinger I; Valent P; Oehler L
In vivo effects of imatinib mesylate on human haematopoietic progenitor cells.
European journal of clinical investigation 2006;36(6):402-8.
2006: Sonneck Karoline; Florian Stefan; Böhm Alexandra; Krauth Maria-Theresa; Kondo Rudin; Hauswirth Alexander W; Gleixner Karoline V; Aichberger Karl J; Derdak Sophia; Pickl Winfried F; Sperr Wolfgang R; Schwartz Lawrence B; Valent Peter
Evaluation of biologic activity of tryptase secreted from blast cells in acute myeloid leukemia.
Leukemia & lymphoma 2006;47(5):897-906.
2006: Rauter Ingrid; Krauth Maria-Theresa; Flicker Sabine; Gieras Anna; Westritschnig Kerstin; Vrtala Susanne; Balic Nadja; Spitzauer Susanne; Huss-Marp Johannes; Brockow Knut; Darsow Ulf; Ring Johannes; Behrendt Heidrun; Semper Hans; Valent Peter; Valenta Rudolf
Allergen cleavage by effector cell-derived proteases regulates allergic inflammation.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2006;20(7):967-9.
2006: Krauth Maria-Theresa; Agis Hermine; Aichberger Karl J; Simonitsch-Klupp Ingrid; Müllauer Leonhard; Mayerhofer Matthias; Böhm Alexandra; Horny Hans-Peter; Valent Peter
Immunohistochemical detection of histidine decarboxylase in neoplastic mast cells in patients with systemic mastocytosis.
Human pathology 2006;37(4):439-47.
2006: Agis H; Krauth M-T; Mosberger I; Müllauer L; Simonitsch-Klupp I; Schwartz L B; Printz D; Böhm A; Fritsch G; Horny H-P; Valent P
Enumeration and immunohistochemical characterisation of bone marrow basophils in myeloproliferative disorders using the basophil specific monoclonal antibody 2D7.
Journal of clinical pathology 2006;59(4):396-402.
2006: Horny H-P; Sotlar K; Stellmacher F; Krokowski M; Agis H; Schwartz L B; Valent P
The tryptase positive compact round cell infiltrate of the bone marrow (TROCI-BM): a novel histopathological finding requiring the application of lineage specific markers.
Journal of clinical pathology 2006;59(3):298-302.
2006: Horny H-P; Sotlar K; Stellmacher F; Valent P; Grabbe J
An unusual case of systemic mastocytosis associated with chronic lymphocytic leukaemia (SM-CLL).
Journal of clinical pathology 2006;59(3):264-8.
2006: Krauth M T; Majlesi Y; Sonneck K; Samorapoompichit P; Ghannadan M; Hauswirth A W; Baghestanian M; Schernthaner G H; Worda C; Müller M R; Sperr W R; Valent P
Effects of various statins on cytokine-dependent growth and IgE-dependent release of histamine in human mast cells.
Allergy 2006;61(3):281-8.
2006: Wimazal Friedrich; Krauth Maria-Theresa; Vales Anja; Böhm Alexandra; Agis Hermine; Sonneck Karoline; Aichberger Karl J; Mayerhofer Matthias; Simonitsch-Klupp Ingrid; Müllauer Leonhard; Sperr Wolfgang R; Valent Peter
Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB category.
Leukemia & lymphoma 2006;47(3):451-60.
2006: Samorapoompichit P; Schernthaner G-H; Worda C; Wimazal F; Krauth M-T; Sperr W R; Valent P
Evaluation of neoplastic human mast cells by tryptase-immunoelectron microscopy.
Histopathology 2006;48(3):247-57.
2006: Krauth Maria-T; Florian Stefan; Böhm Alexandra; Sonneck Karoline; Agis Hermine; Samorapoompichit Puchit; Hauswirth Alexander W; Sperr Wolfgang R; Valent Peter
Immunological characterization and antibacterial function of persisting granulocytes in leukemic patients receiving pulse cytosine arabinoside-consolidation chemotherapy on days 1, 3, and 5.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(3):1759-68.
2006: Agis Hermine; Krauth Maria-Theresa; Böhm Alexandra; Mosberger Isabella; Müllauer Leonhard; Simonitsch-Klupp Ingrid; Walls Andrew F; Horny Hans-Peter; Valent Peter
Identification of basogranulin (BB1) as a novel immunohistochemical marker of basophils in normal bone marrow and patients with myeloproliferative disorders.
American journal of clinical pathology 2006;125(2):273-81.
2006: Florian Stefan; Sonneck Karoline; Hauswirth Alexander W; Krauth Maria-Theresa; Schernthaner Gerit-Holger; Sperr Wolfgang R; Valent Peter
Detection of molecular targets on the surface of CD34+/CD38-- stem cells in various myeloid malignancies.
Leukemia & lymphoma 2006;47(2):207-22.
2006: Füreder Wolfgang; Krauth Maria-Theresa; Sperr Wolfgang R; Sonneck Karoline; Simonitsch-Klupp Ingrid; Müllauer Leonhard; Willmann Michael; Horny Hans-Peter; Valent Peter
Evaluation of angiogenesis and vascular endothelial growth factor expression in the bone marrow of patients with aplastic anemia.
The American journal of pathology 2006;168(1):123-30.
2006: Gleixner Karoline V; Mayerhofer Matthias; Aichberger Karl J; Derdak Sophia; Sonneck Karoline; Böhm Alexandra; Gruze Alexander; Samorapoompichit Puchit; Manley Paul W; Fabbro Doriano; Pickl Winfried F; Sillaber Christian; Valent Peter
PKC412 inhibits in vitro growth of neoplastic human mast cells expressing the D816V-mutated variant of KIT: comparison with AMN107, imatinib, and cladribine (2CdA) and evaluation of cooperative drug effects.
Blood 2006;107(2):752-9.
2006: Hauswirth Alexander W; Florian Stefan; Schernthaner Gerit-Holger; Krauth Maria-Theresa; Sonneck Karoline; Sperr Wolfgang R; Valent Peter
Expression of cell surface antigens on mast cells: mast cell phenotyping.
Methods in molecular biology (Clifton, N.J.) 2006;315():77-90.
2005: Germing U; Hildebrandt B; Pfeilstöcker M; Nösslinger T; Valent P; Fonatsch C; Lübbert M; Haase D; Steidl C; Krieger O; Stauder R; Giagounidis A A N; Strupp C; Kündgen A; Mueller T; Haas R; Gattermann N; Aul C
Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(12):2223-31.
2005: Krauth Maria-Theresa; Bankier Alexander; Valent Peter; Kalhs Peter; Drach Johannes
Sustained remission including marked regression of a paravertebral plasmacytoma in a patient with heavily pretreated, relapsed multiple myeloma after treatment with bortezomib.
Leukemia research 2005;29(12):1473-7.
2005: Sillaber C; Valent P
New insights into the pathogenesis of the hyperimmunoglobulinaemia E syndrome.
European journal of clinical investigation 2005;35(11):667-8.
2005: Aichberger Karl J; Mayerhofer Matthias; Krauth Maria-Theresa; Vales Anja; Kondo Rudin; Derdak Sophia; Pickl Winfried F; Selzer Edgar; Deininger Michael; Druker Brian J; Sillaber Christian; Esterbauer Harald; Valent Peter
Low-level expression of proapoptotic Bcl-2-interacting mediator in leukemic cells in patients with chronic myeloid leukemia: role of BCR/ABL, characterization of underlying signaling pathways, and reexpression by novel pharmacologic compounds.
Cancer research 2005;65(20):9436-44.
2005: Sperr Wolfgang R; Drach Johannes; Hauswirth Alexander W; Ackermann Jutta; Mitterbauer Margit; Mitterbauer Gerlinde; Foedinger Manuela; Fonatsch Christa; Simonitsch-Klupp Ingrid; Kalhs Peter; Valent Peter
Myelomastocytic leukemia: evidence for the origin of mast cells from the leukemic clone and eradication by allogeneic stem cell transplantation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(19 Pt 1):6787-92.
2005: Krauth Maria-Theresa; Majlesi Yasamin; Florian Stefan; Bohm Alexandra; Hauswirth Alexander W; Ghannadan Minoo; Wimazal Friedrich; Raderer Markus; Wrba Friedrich; Valent Peter
Cell surface membrane antigen phenotype of human gastrointestinal mast cells.
International archives of allergy and immunology 2005;138(2):111-20.
2005: Krokowski Manuela; Sotlar Karl; Krauth Maria-Theresa; Födinger Manuela; Valent Peter; Horny Hans-Peter
Delineation of patterns of bone marrow mast cell infiltration in systemic mastocytosis: value of CD25, correlation with subvariants of the disease, and separation from mast cell hyperplasia.
American journal of clinical pathology 2005;124(4):560-8.
2005: Schernthaner G-H; Hauswirth A W; Baghestanian M; Agis H; Ghannadan M; Worda C; Krauth M-T; Printz D; Fritsch G; Sperr W R; Valent P
Detection of differentiation- and activation-linked cell surface antigens on cultured mast cell progenitors.
Allergy 2005;60(10):1248-55.
2005: Agis Hermine; Sotlar Karl; Valent Peter; Horny Hans-Peter
Ph-Chromosome-positive chronic myeloid leukemia with associated bone marrow mastocytosis.
Leukemia research 2005;29(10):1227-32.
2005: Sperr Wolfgang R; Mitterbauer Margit; Mitterbauer Gerlinde; Kundi Michael; Jäger Ulrich; Lechner Klaus; Valent Peter
Quantitation of minimal residual disease in acute myeloid leukemia by tryptase monitoring identifies a group of patients with a high risk of relapse.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(18):6536-43.
2005: Sperr Wolfgang R; Florian Stefan; Hauswirth Alexander W; Valent Peter
CD 33 as a target of therapy in acute myeloid leukemia: current status and future perspectives.
Leukemia & lymphoma 2005;46(8):1115-20.
2005: Aichberger Karl J; Mittermann Irene; Reininger Renate; Seiberler Susanne; Swoboda Ines; Spitzauer Susanne; Kopp Tamara; Stingl Georg; Sperr Wolfgang R; Valent Peter; Repa Andreas; Bohle Barbara; Kraft Dietrich; Valenta Rudolf
Hom s 4, an IgE-reactive autoantigen belonging to a new subfamily of calcium-binding proteins, can induce Th cell type 1-mediated autoreactivity.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(2):1286-94.
2005: Sonneck Karoline; Mannhalter Christine; Krauth Maria-Theresa; Sperr Wolfgang R; Schwarzinger Ilse; Fonatsch Christa; Haas Oskar; Geissler Klaus; Valent Peter
An unusual case of myelodysplastic syndrome with prolonged clonal stability, indolent clinical course over a decade, and spontaneous regression of AML in the terminal phase.
European journal of haematology 2005;75(1):73-7.
2005: Böhm Alexandra; Piribauer Maria; Wimazal Friedrich; Geissler Klaus; Gisslinger Heinz; Knöbl Paul; Jäger Ulrich; Fonatsch Christa; Kyrle Paul A; Valent Peter; Lechner Klaus; Sperr Wolfgang R
High dose intermittent ARA-C (HiDAC) for consolidation of patients with de novo AML: a single center experience.
Leukemia research 2005;29(6):609-15.
2005: Mayerhofer Matthias; Aichberger Karl J; Florian Stefan; Krauth Maria-Theresa; Hauswirth Alexander W; Derdak Sophia; Sperr Wolfgang R; Esterbauer Harald; Wagner Oswald; Marosi Christine; Pickl Winfried F; Deininger Michael; Weisberg Ellen; Druker Brian J; Griffin James D; Sillaber Christian; Valent Peter
Identification of mTOR as a novel bifunctional target in chronic myeloid leukemia: dissection of growth-inhibitory and VEGF-suppressive effects of rapamycin in leukemic cells.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2005;19(8):960-2.
2005: Florian Stefan; Ghannadan Minoo; Mayerhofer Matthias; Aichberger Karl J; Hauswirth Alexander W; Schernthaner Gerit-Holger; Printz Dieter; Fritsch Gerhard; Böhm Alexandra; Sonneck Karoline; Krauth Maria-Theresa; Müller Michael R; Sillaber Christian; Sperr Wolfgang R; Bühring Hans-Jörg; Valent Peter
Evaluation of normal and neoplastic human mast cells for expression of CD172a (SIRPalpha), CD47, and SHP-1.
Journal of leukocyte biology 2005;77(6):984-92.
2005: Linhart Birgit; Hartl Arnulf; Jahn-Schmid Beatrice; Verdino Petra; Keller Walter; Krauth Maria-Theresa; Valent Peter; Horak Friedrich; Wiedermann Ursula; Thalhamer Josef; Ebner Christof; Kraft Dietrich; Valenta Rudolf
A hybrid molecule resembling the epitope spectrum of grass pollen for allergy vaccination.
The Journal of allergy and clinical immunology 2005;115(5):1010-6.
2005: Reisinger Jürgen; Triendl Andrea; Küchler Ernst; Bohle Barbara; Krauth Maria Theresa; Rauter Ingrid; Valent Peter; Koenig Franz; Valenta Rudolf; Niederberger Verena
IFN-gamma-enhanced allergen penetration across respiratory epithelium augments allergic inflammation.
The Journal of allergy and clinical immunology 2005;115(5):973-81.
2005: Aichberger Karl J; Mayerhofer Matthias; Krauth Maria-Theresa; Skvara Hans; Florian Stefan; Sonneck Karoline; Akgul Cahit; Derdak Sophia; Pickl Winfried F; Wacheck Volker; Selzer Edgar; Monia Brett P; Moriggl Richard; Valent Peter; Sillaber Christian
Identification of mcl-1 as a BCR/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides.
Blood 2005;105(8):3303-11.
2005: Florian Stefan; Krauth Maria-Theresa; Simonitsch-Klupp Ingrid; Sperr Wolfgang R; Fritsche-Polanz Robert; Sonneck Karoline; Födinger Manuela; Agis Hermine; Böhm Alexandra; Wimazal Friedrich; Horny Hans-Peter; Valent Peter
Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes.
International archives of allergy and immunology 2005;136(3):273-80.
2005: Batard Thierry; Didierlaurent Alain; Chabre Henri; Mothes Nadine; Bussières Laetitia; Bohle Barbara; Couret Marie-Noëlle; Ball Tanja; Lemoine Pierrick; Focks Tejkl Margarete; Chenal Alexandre; Clément Gilles; Dupont Francis; Valent Peter; Krauth Marie-Theres; André Claude; Valenta Rudolf; Moingeon Philippe
Characterization of wild-type recombinant Bet v 1a as a candidate vaccine against birch pollen allergy.
International archives of allergy and immunology 2005;136(3):239-49.
2005: Ball Tanja; Edstrom William; Mauch Ludwig; Schmitt Jacky; Leistler Bernd; Fiebig Helmut; Sperr Wolfgang R; Hauswirth Alexander W; Valent Peter; Kraft Dietrich; Almo Steven C; Valenta Rudolf
Gain of structure and IgE epitopes by eukaryotic expression of the major Timothy grass pollen allergen, Phl p 1.
The FEBS journal 2005;272(1):217-27.
2005: Valent Peter; Akin Cem; Sperr Wolfgang R; Mayerhofer Matthias; Födinger Manuela; Fritsche-Polanz Robert; Sotlar Karl; Escribano Luis; Arock Michel; Horny Hans-Peter; Metcalfe Dean D
Mastocytosis: pathology, genetics, and current options for therapy.
Leukemia & lymphoma 2005;46(1):35-48.
2005: Ziegler Sophie; Sperr Wolfgang R; Knöbl Paul; Lehr Stephan; Weltermann Ansgar; Jäger Ulrich; Valent Peter; Lechner Klaus
Symptomatic venous thromboembolism in acute leukemia. Incidence, risk factors, and impact on prognosis.
Thrombosis research 2005;115(1-2):59-64.
2004: Noack Frank; Sotlar Karl; Notter Martin; Thiel Eckhard; Valent Peter; Horny Hans-Peter
Aleukemic mast cell leukemia with abnormal immunophenotype and c-kit mutation D816V.
Leukemia & lymphoma 2004;45(11):2295-302.
2004: Valent Peter; Arock Michel; Bischoff Stephan C; Bühring Hans-Jörg; Brockow Knut; Escribano Luis; Födinger Manuela; Grabbe Jürgen; Hartmann Karin; Henz Beate M; Horny Hans-Peter; Kluin-Nelemans Hanneke C; Lima Margarida; Marone Gianni; Orfao Alberto; Parwaresch Reza M; Sillaber Christian; Sotlar Karl; Sperr Wolfgang R; Triggiani Massimo; Van Doormaal Jaap J; Wolff Klaus; Zuberbier Torsten
The European Competence Network on Mastocytosis (ECNM).
Wiener klinische Wochenschrift 2004;116(19-20):647-51.
2004: Focke M; Linhart B; Hartl A; Wiedermann U; Sperr W R; Valent P; Thalhamer J; Kraft D; Valenta R
Non-anaphylactic surface-exposed peptides of the major birch pollen allergen, Bet v 1, for preventive vaccination.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2004;34(10):1525-33.
2004: Sotlar Karl; Horny Hans-Peter; Simonitsch Ingrid; Krokowski Manuela; Aichberger Karl J; Mayerhofer Matthias; Printz Dieter; Fritsch Gerhard; Valent Peter
CD25 indicates the neoplastic phenotype of mast cells: a novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens.
The American journal of surgical pathology 2004;28(10):1319-25.
2004: Niederberger V; Horak F; Vrtala S; Spitzauer S; Krauth M-T; Valent P; Reisinger J; Pelzmann M; Hayek B; Kronqvist M; Gafvelin G; Grönlund H; Purohit A; Suck R; Fiebig H; Cromwell O; Pauli G; van Hage-Hamsten M; Valenta R
Vaccination with genetically engineered allergens prevents progression of allergic disease.
Proceedings of the National Academy of Sciences of the United States of America 2004;101 Suppl 2():14677-82.
2004: Valent P; Ghannadan M; Akin C; Krauth M-T; Selzer E; Mayerhofer M; Sperr W R; Arock M; Samorapoompichit P; Horny H-P; Metcalfe D D
On the way to targeted therapy of mast cell neoplasms: identification of molecular targets in neoplastic mast cells and evaluation of arising treatment concepts.
European journal of clinical investigation 2004;34 Suppl 2():41-52.
2004: Sperr W R; Hauswirth A W; Florian S; Ohler L; Geissler K; Valent P
Human leukaemic stem cells: a novel target of therapy.
European journal of clinical investigation 2004;34 Suppl 2():31-40.
2004: Sillaber C; Mayerhofer M; Aichberger K J; Krauth M-T; Valent P
Expression of angiogenic factors in chronic myeloid leukaemia: role of the bcr/abl oncogene, biochemical mechanisms, and potential clinical implications.
European journal of clinical investigation 2004;34 Suppl 2():2-11.
2004: Agis Hermine; Mannhalter Christine; Sperr Wolfgang R; Keil Felix; Kalhs Peter; Pirc-Danoewinata Hendrati; Krauth Maria-Theresa; Haas Oskar A; Geissler Klaus; Lechner Klaus; Valent Peter
Detection of trisomy 8 in donor-derived Ph- cells in a patient with Ph+ chronic myeloid leukemia successfully treated with Imatinib (STI571) in relapse after allogeneic transplantation.
Leukemia & lymphoma 2004;45(7):1453-8.
2004: Valent Peter; Sperr Wolfgang R; Schwartz Lawrence B; Horny Hans-Peter
Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms.
The Journal of allergy and clinical immunology 2004;114(1):3-11; quiz 12.
2004: Sperr Wolfgang R; Piribauer Maria; Wimazal Friedrich; Fonatsch Christa; Thalhammer-Scherrer Renate; Schwarzinger Ilse; Geissler Klaus; Knöbl Paul; Jäger Ulrich; Lechner Klaus; Valent Peter
A novel effective and safe consolidation for patients over 60 years with acute myeloid leukemia: intermediate dose cytarabine (2 x 1 g/m2 on days 1, 3, and 5).
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(12 Pt 1):3965-71.
2004: Horny H-P; Sotlar K; Sperr W R; Valent P
Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge.
Journal of clinical pathology 2004;57(6):604-8.
2004: Valent Peter; Fonatsch Christa; Stindl Reinhard; Schwarzinger Ilse; Haas Oskar A; Sperr Wolfgang R; Geissler Klaus; Lechner Klaus
Normal bone marrow function over 6 years in a patient with dysplastic hematopoiesis and a complex karyotype.
Leukemia research 2004;28(6):651-5.
2004: Swoboda Ines; Grote Monika; Verdino Petra; Keller Walter; Singh Mohan B; De Weerd Nicole; Sperr Wolfgang R; Valent Peter; Balic Nadja; Reichelt Rudolf; Suck Roland; Fiebig Helmut; Valenta Rudolf; Spitzauer Susanne
Molecular characterization of polygalacturonases as grass pollen-specific marker allergens: expulsion from pollen via submicronic respirable particles.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(10):6490-500.
2004: Mayerhofer Matthias; Florian Stefan; Krauth Maria-Theresa; Aichberger Karl J; Bilban Martin; Marculescu Rodrig; Printz Dieter; Fritsch Gerhard; Wagner Oswald; Selzer Edgar; Sperr Wolfgang R; Valent Peter; Sillaber Christian
Identification of heme oxygenase-1 as a novel BCR/ABL-dependent survival factor in chronic myeloid leukemia.
Cancer research 2004;64(9):3148-54.
2004: Westritschnig Kerstin; Focke Margarete; Verdino Petra; Goessler Walter; Keller Walter; Twardosz Anna; Mari Adriano; Horak Friedrich; Wiedermann Ursula; Hartl Arnulf; Thalhamer Josef; Sperr Wolfgang R; Valent Peter; Valenta Rudolf
Generation of an allergy vaccine by disruption of the three-dimensional structure of the cross-reactive calcium-binding allergen, Phl p 7.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(9):5684-92.
2004: Stellmacher Florian; Sotlar Karl; Balleisen Leopold; Valent Peter; Horny Hans-Peter
Bone marrow mastocytosis associated with IgM kappa plasma cell myeloma.
Leukemia & lymphoma 2004;45(4):801-5.
2004: Wimazal Friedrich; Schwarzmeier Josef; Sotlar Karl; Simonitsch Ingrid; Sperr Wolfgang R; Fritsche-Polanz Robert; Födinger Manuela; Schubert Jörg; Horny Hans-Peter; Valent Peter
Splenic mastocytosis: report of two cases and detection of the transforming somatic C-KIT mutation D816V.
Leukemia & lymphoma 2004;45(4):723-9.
2004: Krauth Maria-Theresa; Simonitsch Ingrid; Aichberger Karl J; Mayerhofer Matthias; Sperr Wolfgang R; Sillaber Christian; Schneeweiss Bruno; Mann Georg; Gadner Helmut; Valent Peter
Immunohistochemical detection of VEGF in the bone marrow of patients with chronic myeloid leukemia and correlation with the phase of disease.
American journal of clinical pathology 2004;121(4):473-81.
2004: Bühring Hans-Jörg; Streble Anna; Valent Peter
The basophil-specific ectoenzyme E-NPP3 (CD203c) as a marker for cell activation and allergy diagnosis.
International archives of allergy and immunology 2004;133(4):317-29.
2004: Bernd H-W; Sotlar K; Lorenzen J; Osieka R; Fabry U; Valent P; Horny H-P
Acute myeloid leukaemia with t(8;21) associated with "occult" mastocytosis. Report of an unusual case and review of the literature.
Journal of clinical pathology 2004;57(3):324-8.
2004: Valent Peter; Hauswirth Alexander W; Natter Susanne; Sperr Wolfgang R; Bühring Hans-Jörg; Valenta Rudolf
Assays for measuring in vitro basophil activation induced by recombinant allergens.
Methods (San Diego, Calif.) 2004;32(3):265-70.
2004: Hauswirth Alexander W; Simonitsch-Klupp Ingrid; Uffmann Martin; Koller Elisabeth; Sperr Wolfgang R; Lechner Klaus; Valent Peter
Response to therapy with interferon alpha-2b and prednisolone in aggressive systemic mastocytosis: report of five cases and review of the literature.
Leukemia research 2004;28(3):249-57.
2004: Weltermann A; Fonatsch C; Haas O A; Greinix H T; Kahls P; Mitterbauer G; Jäger U; Kainz B; Geissler K; Valent P; Sperr W R; Knöbl P; Schwarzinger I; Gleiss A; Lechner K
Impact of cytogenetics on the prognosis of adults with de novo AML in first relapse.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(2):293-302.
2003: Reininger R; Swoboda I; Bohle B; Hauswirth A W; Valent P; Rumpold H; Valenta R; Spitzauer S
Characterization of recombinant cat albumin.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2003;33(12):1695-702.
2003: Valent Peter; Akin Cem; Sperr Wolfgang R; Horny Hans-Peter; Metcalfe Dean D
Mast cell proliferative disorders: current view on variants recognized by the World Health Organization.
Hematology/oncology clinics of North America 2003;17(5):1227-41.
2003: Li Shuren; Dudczak Robert; Koller Elisabeth; Baghestanian Mehrdad; Ghannadan Minoo; Minar Erich; Pirich Christian; Angelberger Peter; Virgolini Irene; Li Mei; Valent Peter
Effect of statins on lipoprotein receptor expression in cell lines from human mast cells and basophils.
European journal of clinical pharmacology 2003;59(7):507-16.
2003: Grönlund Hans; Bergman Tomas; Sandström Kristofer; Alvelius Gunvor; Reininger Renate; Verdino Petra; Hauswirth Alexander; Liderot Karin; Valent Peter; Spitzauer Susanne; Keller Walter; Valenta Rudolf; van Hage-Hamsten Marianne
Formation of disulfide bonds and homodimers of the major cat allergen Fel d 1 equivalent to the natural allergen by expression in Escherichia coli.
The Journal of biological chemistry 2003;278(41):40144-51.
2003: Wojta Johann; Huber Kurt; Valent Peter
New aspects in thrombotic research: complement induced switch in mast cells from a profibrinolytic to a prothrombotic phenotype.
Pathophysiology of haemostasis and thrombosis 2003;33(5-6):438-41.
2003: Mothes N; Heinzkill M; Drachenberg K J; Sperr W R; Krauth M T; Majlesi Y; Semper H; Valent P; Niederberger V; Kraft D; Valenta R
Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2003;33(9):1198-208.
2003: Valent Peter; Akin Cem; Sperr Wolfgang R; Horny Hans-P; Arock Michel; Lechner Klaus; Bennett John M; Metcalfe Dean D
Diagnosis and treatment of systemic mastocytosis: state of the art.
British journal of haematology 2003;122(5):695-717.
2003: Valent Peter; Wimazal Friedrich; Schwarzinger Ilse; Sperr Wolfgang R; Geissler Klaus
Pathogenesis, classification, and treatment of myelodysplastic syndromes (MDS).
Wiener klinische Wochenschrift 2003;115(13-14):515-36.
2003: Sperr Wolfgang R; Hauswirth Alexander W; Wimazal Friedrich; Knöbl Paul; Geissler Klaus; Valent Peter
Treatment concepts for elderly patients with acute myeloid leukemia.
Wiener klinische Wochenschrift 2003;115(13-14):505-14.
2003: Sillaber Christian; Mayerhofer Matthias; Agis Hermine; Sagaster Verena; Mannhalter Christine; Sperr Wolfgang R; Geissler Klaus; Valent Peter
Chronic myeloid leukemia: pathophysiology, diagnostic parameters, and current treatment concepts.
Wiener klinische Wochenschrift 2003;115(13-14):485-504.
2003: Horny H-P; Lange K; Sotlar K; Valent P
Increase of bone marrow lymphocytes in systemic mastocytosis: reactive lymphocytosis or malignant lymphoma? Immunohistochemical and molecular findings on routinely processed bone marrow biopsy specimens.
Journal of clinical pathology 2003;56(8):575-8.
2003: Chott Andreas; Guenther Philipp; Huebner Angela; Selzer Edgar; Parwaresch Reza M; Horny Hans-Peter; Valent Peter
Morphologic and immunophenotypic properties of neoplastic cells in a case of mast cell sarcoma.
The American journal of surgical pathology 2003;27(7):1013-9.
2003: Jordan J-H; Jäger E; Sperr W R; Schwarzinger I; Födinger M; Fritsche-Polanz R; Ohler L; Geissler K; Valent P
Numbers of colony-forming progenitors in patients with systemic mastocytosis: potential diagnostic implications and comparison with myeloproliferative disorders.
European journal of clinical investigation 2003;33(7):611-8.
2003: Valent Peter; Akin Cem; Sperr Wolfgang R; Escribano Luis; Arock Michel; Horny Hans-Peter; Bennett John M; Metcalfe Dean D
Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria.
Leukemia research 2003;27(7):635-41.
2003: Laffer Sylvia; Hamdi Said; Lupinek Christian; Sperr Wolfgang R; Valent Peter; Verdino Petra; Keller Walter; Grote Monika; Hoffmann-Sommergruber Karin; Scheiner Otto; Kraft Dietrich; Rideau Marc; Valenta Rudolf
Molecular characterization of recombinant T1, a non-allergenic periwinkle (Catharanthus roseus) protein, with sequence similarity to the Bet v 1 plant allergen family.
The Biochemical journal 2003;373(Pt 1):261-9.
2003: Ghannadan Minoo; Wimazal Friedrich; Simonitsch Ingrid; Sperr Wolfgang R; Mayerhofer Matthias; Sillaber Christian; Hauswirth Alexander W; Gadner Helmut; Chott Andreas; Horny Hans-Peter; Lechner Klaus; Valent Peter
Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
American journal of clinical pathology 2003;119(5):663-71.
2003: Berer A; Jäger E; Sagaster V; Streubel B; Wimazal F; Sperr W R; Welterman A; Schwarzinger I; Frommlet F; Haas O A; Valent P; Lechner K; Geissler K; Ohler L
Circulating myeloid colony-forming cells predict survival in myelodysplastic syndromes.
Annals of hematology 2003;82(5):271-7.
2003: Samorapoompichit Puchit; Steiner Marianne; Lucas Trevor; Wachtler Franz; Schedled Andreas; Sperr Wolfgang R; Valent Peter
Induction of apoptosis in the human mast cell leukemia cell line HMC-1 by various antineoplastic drugs.
Leukemia & lymphoma 2003;44(3):509-15.
2003: Rezaie-Majd Abdolreza; Prager Gerald W; Bucek Robert A; Schernthaner Gerit H; Maca Thomas; Kress Hans-Georg; Valent Peter; Binder Bernd R; Minar Erich; Baghestanian Mehrdad
Simvastatin reduces the expression of adhesion molecules in circulating monocytes from hypercholesterolemic patients.
Arteriosclerosis, thrombosis, and vascular biology 2003;23(3):397-403.
2003: Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny H P
Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
Leukemia & lymphoma 2003;44(2):313-9.
2003: Horny H-P; Greschniok A; Jordan J-H; Menke D M; Valent P
Chymase expressing bone marrow mast cells in mastocytosis and myelodysplastic syndromes: an immunohistochemical and morphometric study.
Journal of clinical pathology 2003;56(2):103-6.
2003: Núñez-López Rosa; Escribano Luis; Schernthaner Gerit-Holger; Prados Aránzazu; Rodríguez-González Ramón; Díaz-Agustín Beatriz; López Antonio; Hauswirth Alexander; Valent Peter; Almeida Julia; Bravo Pilar; Orfao Alberto
Overexpression of complement receptors and related antigens on the surface of bone marrow mast cells in patients with systemic mastocytosis.
British journal of haematology 2003;120(2):257-65.
2003: Majlesi Yasamin; Samorapoompichit Puchit; Hauswirth Alexander W; Schernthaner Gerit-Holger; Ghannadan Minoo; Baghestanian Mehrdad; Rezaie-Majd Abdolreza; Valenta Rudolf; Sperr Wolfgang R; Bühring Hans-Jörg; Valent Peter
Cerivastatin and atorvastatin inhibit IL-3-dependent differentiation and IgE-mediated histamine release in human basophils and downmodulate expression of the basophil-activation antigen CD203c/E-NPP3.
Journal of leukocyte biology 2003;73(1):107-17.
2002: Sperr Wolfgang R; Hauswirth Alexander W; Valent Peter
Tryptase a novel biochemical marker of acute myeloid leukemia.
Leukemia & lymphoma 2002;43(12):2257-61.
2002: Baghestanian Mehrdad; Jordan John-Hendrik; Kiener Hans P; Bevec Dorian; Agis Hermine; Fritsch Gerhard; Müller Michael R; Bankl Hans C; Schernthaner Gerit-Holger; Lechner Klaus; Valent Peter
Activation of human mast cells through stem cell factor receptor (KIT) is associated with expression of bcl-2.
International archives of allergy and immunology 2002;129(3):228-36.
2002: Mayerhofer Matthias; Valent Peter; Sperr Wolfgang R; Griffin James D; Sillaber Christian
BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin.
Blood 2002;100(10):3767-75.
2002: Zettinig Georg; Becherer Alexander; Szabo Monika; Uffmann Martin; Dudczak Robert; Valent Peter; Kletter Kurt
FDG positron emission tomography in patients with systemic mastocytosis.
AJR. American journal of roentgenology 2002;179(5):1235-7.
2002: Sotlar Karl; Fridrich Claudius; Mall Adelheid; Jaussi Ralf; Bültmann Burkhard; Valent Peter; Horny Hans-Peter
Detection of c-kit point mutation Asp-816 --> Val in microdissected pooled single mast cells and leukemic cells in a patient with systemic mastocytosis and concomitant chronic myelomonocytic leukemia.
Leukemia research 2002;26(11):979-84.
2002: Binder Marc; Fierlbeck Gerhard; King Te iaoP; Valent Peter; Bühring Hans-Jörg
Individual hymenoptera venom compounds induce upregulation of the basophil activation marker ectonucleotide pyrophosphatase/phosphodiesterase 3 (CD203c) in sensitized patients.
International archives of allergy and immunology 2002;129(2):160-8.
2002: Stumvoll Sabine; Lidholm Jonas; Thunberg Roland; DeWitt Asa Marknell; Eibensteiner Petra; Swoboda Ines; Bugajska-Schretter Agnes; Spitzauer Susanne; Vangelista Luca; Kazemi-Shirazi Lili; Sperr Wolfgang R; Valent Peter; Kraft Dietrich; Valenta Rudolf
Purification, structural and immunological characterization of a timothy grass (Phleum pratense) pollen allergen, Phl p 4, with cross-reactive potential.
Biological chemistry 2002;383(9):1383-96.
2002: Marknell DeWitt A; Niederberger V; Lehtonen P; Spitzauer S; Sperr W R; Valent P; Valenta R; Lidholm J
Molecular and immunological characterization of a novel timothy grass (Phleum pratense) pollen allergen, Phl p 11.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2002;32(9):1329-40.
2002: Flicker Sabine; Steinberger Peter; Norderhaug Lars; Sperr Wolfgang R; Majlesi Yasamin; Valent Peter; Kraft Dietrich; Valenta Rudolf
Conversion of grass pollen allergen-specific human IgE into a protective IgG(1) antibody.
European journal of immunology 2002;32(8):2156-62.
2002: Rezaie-Majd Abdolreza; Maca Thomas; Bucek Robert A; Valent Peter; Müller Michael R; Husslein Peter; Kashanipour Ahmad; Minar Erich; Baghestanian Mehrdad
Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients.
Arteriosclerosis, thrombosis, and vascular biology 2002;22(7):1194-9.
2002: Hauswirth Alexander W; Natter Susanne; Ghannadan Minoo; Majlesi Yasamin; Schernthaner Gerit-Holger; Sperr Wolfgang R; Bühring Hans-Jörg; Valenta Rudolf; Valent Peter
Recombinant allergens promote expression of CD203c on basophils in sensitized individuals.
The Journal of allergy and clinical immunology 2002;110(1):102-9.
2002: Wojta Johann; Kaun Christoph; Zorn Gerlinde; Ghannadan Minoo; Hauswirth Alexander W; Sperr Wolfgang R; Fritsch Gerhard; Printz Dieter; Binder Bernd R; Schatzl Georg; Zwirner Joerg; Maurer Gerald; Huber Kurt; Valent Peter
C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophils.
Blood 2002;100(2):517-23.
2002: Sperr Wolfgang R; Jordan John-Hendrik; Fiegl Michael; Escribano Luis; Bellas Carmen; Dirnhofer Stephan; Semper Hans; Simonitsch-Klupp Ingrid; Horny Hans-Peter; Valent Peter
Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease.
International archives of allergy and immunology 2002;128(2):136-41.
2002: Hauswirth Alexander W; Sperr Wolfgang R; Ghannadan Minoo; Schernthaner Gerit Holger; Jordan John Hendrik; Fritsche-Polanz Robert; Simonitsch-Klupp Ingrid; Födinger Manuela; Lechner Klaus; Valent Peter
A case of smouldering mastocytosis with peripheral blood eosinophilia and lymphadenopathy.
Leukemia research 2002;26(6):601-6.
2002: Sperr W R; Stehberger B; Wimazal F; Baghestanian M; Schwartz L B; Kundi M; Semper H; Jordan J H; Chott A; Drach J; Jäger U; Geissler K; Greschniok A; Horny H P; Lechner K; Valent P
Serum tryptase measurements in patients with myelodysplastic syndromes.
Leukemia & lymphoma 2002;43(5):1097-105.
2002: Valent Peter; Ghannadan Minoo; Hauswirth Alexander W; Schernthaner Gerit-Holger; Sperr Wolfgang R; Arock Michel
Signal transduction-associated and cell activation-linked antigens expressed in human mast cells.
International journal of hematology 2002;75(4):357-62.
2002: Valent P; Baghestanian M; Bankl H C; Sillaber C; Sperr W R; Wojta J; Binder B R; Lechner K
New aspects in thrombosis research: possible role of mast cells as profibrinolytic and antithrombotic cells.
Thrombosis and haemostasis 2002;87(5):786-90.
2002: Wimazal Friedrich; Jordan John-Hendrik; Sperr Wolfgang R; Chott Andreas; Dabbass Sana; Lechner Klaus; Horny Hans P; Valent Peter
Increased angiogenesis in the bone marrow of patients with systemic mastocytosis.
The American journal of pathology 2002;160(5):1639-45.
2002: Swoboda Ines; Bugajska-Schretter Agnes; Verdino Petra; Keller Walter; Sperr Wolfgang R; Valent Peter; Valenta Rudolf; Spitzauer Susanne
Recombinant carp parvalbumin, the major cross-reactive fish allergen: a tool for diagnosis and therapy of fish allergy.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(9):4576-84.
2002: Ghannadan Minoo; Hauswirth Alexander W; Schernthaner Gerit-Holger; Müller Michael R; Klepetko Walter; Schatzl Georg; Sperr Wolfgang R; Bühring Hans-Jörg; Valent Peter
Detection of novel CD antigens on the surface of human mast cells and basophils.
International archives of allergy and immunology 2002;127(4):299-307.
2002: Kazemi-Shirazi L; Gasche C H; Natter S; Gangl A; Smolen J; Spitzauer S; Valent P; Kraft D; Valenta R
IgA autoreactivity: a feature common to inflammatory bowel and connective tissue diseases.
Clinical and experimental immunology 2002;128(1):102-9.
2002: Horny Hans-Peter; Krokowski Manuela; Feller Alfred C; Hintze Gerhard; Sotlar Karl; Valent Peter
[Aleukemic mast cell leukemia (formerly: "malignant mastocytosis"): an extremely rare form of leukemia. A case report and simultaneously a contribution to revised classification of mastocytosis]
Wiener klinische Wochenschrift 2002;114(5-6):222-8.
2002: Jordan John-Hendrik; Schernthaner Gerit-Holger; Fritsche-Polanz Robert; Sperr Wolfgang R; Födinger Manuela; Chott Andreas; Geissler Klaus; Lechner Klaus; Horny Hans-Peter; Valent Peter
Stem cell factor-induced bone marrow mast cell hyperplasia mimicking systemic mastocytosis (SM): histopathologic and morphologic evaluation with special reference to recently established SM-criteria.
Leukemia & lymphoma 2002;43(3):575-82.
2002: Bankl Hans C; Valent Peter
Mast cells, thrombosis, and fibrinolysis: the emerging concept.
Thrombosis research 2002;105(4):359-65.
2002: Sperr Wolfgang R; Horny Hans-Peter; Valent Peter
Spectrum of associated clonal hematologic non-mast cell lineage disorders occurring in patients with systemic mastocytosis.
International archives of allergy and immunology 2002;127(2):140-2.
2002: Valent Peter; Akin Cem; Sperr Wolfgang R; Horny Hans-Peter; Metcalfe Dean D
Smouldering mastocytosis: a novel subtype of systemic mastocytosis with slow progression.
International archives of allergy and immunology 2002;127(2):137-9.
2002: Horny Hans-Peter; Valent Peter
Histopathological and immunohistochemical aspects of mastocytosis.
International archives of allergy and immunology 2002;127(2):115-7.
2002: Agis H; Weltermann A; Fonatsch C; Haas O; Mitterbauer G; Müllauer L; Schreiber S; Schwarzinger I; Juretzka W; Valent P; Jäger U; Lechner K; Geissler K
A comparative study on demographic, hematological, and cytogenetic findings and prognosis in acute myeloid leukemia with and without leukemia cutis.
Annals of hematology 2002;81(2):90-5.
2002: Swoboda Ines; De Weerd Nicole; Bhalla Prem L; Niederberger Verena; Sperr W R; Valent Peter; Kahlert Helga; Fiebig Helmut; Verdino Petra; Keller Walter; Ebner Christof; Spitzauer Susanne; Valenta Rudolf; Singh Mohan B
Mutants of the major ryegrass pollen allergen, Lol p 5, with reduced IgE-binding capacity: candidates for grass pollen-specific immunotherapy.
European journal of immunology 2002;32(1):270-80.
2002: Valent Peter; Samorapoompichit Puchit; Sperr Wolfgang R; Horny Hans-Peter; Lechner Klaus
Myelomastocytic leukemia: myeloid neoplasm characterized by partial differentiation of mast cell-lineage cells.
The hematology journal : the official journal of the European Haematology Association / EHA 2002;3(2):90-4.
2001: Platz I J; Binder M; Marxer A; Lischka G; Valent P; Bühring H J
Hymenoptera-venom-induced upregulation of the basophil activation marker ecto-nucleotide pyrophosphatase/phosphodiesterase 3 in sensitized individuals.
International archives of allergy and immunology 2001;126(4):335-42.
2001: Schernthaner G H; Jordan J H; Ghannadan M; Agis H; Bevec D; Nuñez R; Escribano L; Majdic O; Willheim M; Worda C; Printz D; Fritsch G; Lechner K; Valent P
Expression, epitope analysis, and functional role of the LFA-2 antigen detectable on neoplastic mast cells.
Blood 2001;98(13):3784-92.
2001: Binder M; Mahler V; Hayek B; Sperr W R; Schöller M; Prozell S; Wiedermann G; Valent P; Valenta R; Duchêne M
Molecular and immunological characterization of arginine kinase from the Indianmeal moth, Plodia interpunctella, a novel cross-reactive invertebrate pan-allergen.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(9):5470-7.
2001: Füreder W; Schernthaner G H; Ghannadan M; Hauswirth A; Sperr W R; Semper H; Majlesi Y; Zwirner J; Götze O; Bühring H J; Lechner K; Valent P
Quantitative, phenotypic, and functional evaluation of basophils in myelodysplastic syndromes.
European journal of clinical investigation 2001;31(10):894-901.
2001: Samorapoompichit P; Kiener H P; Schernthaner G H; Jordan J H; Agis H; Wimazal F; Baghestanian M; Rezaie-Majd A; Sperr W R; Lechner K; Valent P
Detection of tryptase in cytoplasmic granules of basophils in patients with chronic myeloid leukemia and other myeloid neoplasms.
Blood 2001;98(8):2580-3.
2001: Sperr W R; Jordan J H; Baghestanian M; Kiener H P; Samorapoompichit P; Semper H; Hauswirth A; Schernthaner G H; Chott A; Natter S; Kraft D; Valenta R; Schwartz L B; Geissler K; Lechner K; Valent P
Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia.
Blood 2001;98(7):2200-9.
2001: Laffer S; Hogbom E; Roux K H; Sperr W R; Valent P; Bankl H C; Vangelista L; Kricek F; Kraft D; Grönlund H; Valenta R
A molecular model of type I allergy: identification and characterization of a nonanaphylactic anti-human IgE antibody fragment that blocks the IgE-FcepsilonRI interaction and reacts with receptor-bound IgE.
The Journal of allergy and clinical immunology 2001;108(3):409-16.
2001: Focke M; Mahler V; Ball T; Sperr W R; Majlesi Y; Valent P; Kraft D; Valenta R
Nonanaphylactic synthetic peptides derived from B cell epitopes of the major grass pollen allergen, Phl p 1, for allergy vaccination.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2001;15(11):2042-4.
2001: Vrtala S; Hirtenlehner K; Susani M; Akdis M; Kussebi F; Akdis C A; Blaser K; Hufnagl P; Binder B R; Politou A; Pastore A; Vangelista L; Sperr W R; Semper H; Valent P; Ebner C; Kraft D; Valenta R
Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen Bet v 1.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2001;15(11):2045-7.
2001: Fonatsch C; Nowotny H; Pittermann-Höcker E; Streubel B; Jäger U; Valent P; Büchner T; Lechner K
Amplification of ribosomal RNA genes in acute myeloid leukemia.
Genes, chromosomes & cancer 2001;32(1):11-7.
2001: Bankl H C; Samorapoompichit P; Pikula B; Latinovic L; Bankl H; Lechner K; Valent P
Characterization of human prostate mast cells and their increase in periprostatic vein thrombosis.
American journal of clinical pathology 2001;116(1):97-106.
2001: Jordan J H; Fritsche-Polanz R; Sperr W R; Mitterbauer G; Födinger M; Schernthaner G H; Christian Bankl H; Gebhart W; Chott A; Lechner K; Valent P
A case of 'smouldering' mastocytosis with high mast cell burden, monoclonal myeloid cells, and C-KIT mutation Asp-816-Val.
Leukemia research 2001;25(7):627-34.
2001: Valent P; Horny H P; Escribano L; Longley B J; Li C Y; Schwartz L B; Marone G; Nuñez R; Akin C; Sotlar K; Sperr W R; Wolff K; Brunning R D; Parwaresch R M; Austen K F; Lennert K; Metcalfe D D; Vardiman J W; Bennett J M
Diagnostic criteria and classification of mastocytosis: a consensus proposal.
Leukemia research 2001;25(7):603-25.
2001: Valent P; Sperr W R; Samorapoompichit P; Geissler K; Lechner K; Horny H P; Bennett J M
Myelomastocytic overlap syndromes: biology, criteria, and relationship to mastocytosis.
Leukemia research 2001;25(7):595-602.
2001: Escribano L; Díaz-Agustín B; Bellas C; Navalón R; Nuñez R; Sperr W R; Schernthaner G H; Valent P; Orfao A
Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis.
Leukemia research 2001;25(7):563-70.
2001: Horny H P; Valent P
Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings.
Leukemia research 2001;25(7):543-51.
2001: Sperr W R; Escribano L; Jordan J H; Schernthaner G H; Kundi M; Horny H P; Valent P
Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis.
Leukemia research 2001;25(7):529-36.
2001: Sperr W R; Wimazal F; Kundi M; Fonatsch C; Thalhammer-Scherrer R; Schernthaner G H; Schwarzinger I; Haas O A; Geissler K; Lechner K; Valent P
Survival analysis and AML development in patients with de novo myelodysplastic syndromes: comparison of six different prognostic scoring systems.
Annals of hematology 2001;80(5):272-7.
2001: Jordan J H; Walchshofer S; Jurecka W; Mosberger I; Sperr W R; Wolff K; Chott A; Bühring H J; Lechner K; Horny H P; Valent P
Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L).
Human pathology 2001;32(5):545-52.
2001: Fritsche-Polanz R; Jordan J H; Feix A; Sperr W R; Sunder-Plassmann G; Valent P; Födinger M
Mutation analysis of C-KIT in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis.
British journal of haematology 2001;113(2):357-64.
2001: Bühring H J; Seiffert M; Giesert C; Marxer A; Kanz L; Valent P; Sano K
The basophil activation marker defined by antibody 97A6 is identical to the ectonucleotide pyrophosphatase/phosphodiesterase 3.
Blood 2001;97(10):3303-5.
2001: Wimazal F; Sperr W R; Kundi M; Meidlinger P; Fonatsch C; Jordan J H; Thalhammer-Scherrer R; Schwarzinger I; Geissler K; Lechner K; Valent P
Prognostic value of lactate dehydrogenase activity in myelodysplastic syndromes.
Leukemia research 2001;25(4):287-94.
2001: Li S; Peck-Radosavljevic M; Koller E; Koller F; Kaserer K; Kreil A; Kapiotis S; Hamwi A; Weich H A; Valent P; Angelberger P; Dudczak R; Virgolini I
Characterization of (123)I-vascular endothelial growth factor-binding sites expressed on human tumour cells: possible implication for tumour scintigraphy.
International journal of cancer. Journal international du cancer 2001;91(6):789-96.
2001: Natter S; Granditsch G; Reichel G L; Baghestanian M; Valent P; Elfman L; Grönlund H; Kraft D; Valenta R
IgA cross-reactivity between a nuclear autoantigen and wheat proteins suggests molecular mimicry as a possible pathomechanism in celiac disease.
European journal of immunology 2001;31(3):918-28.
2001: Valent P; Schernthaner G H; Sperr W R; Fritsch G; Agis H; Willheim M; Bühring H J; Orfao A; Escribano L
Variable expression of activation-linked surface antigens on human mast cells in health and disease.
Immunological reviews 2001;179():74-81.
2001: Li S R; Koller E; Valent P; Gludovacz D; Yang Q; Patri P; Angelberger P; Dudczak R; Virgolini I
Effects of vasoactive intestinal peptide (VIP) and somatostatin (SST) on lipoprotein receptor expression by A431 tumor cells.
Life sciences 2001;68(11):1243-57.
2001: Streubel B; Valent P; Lechner K; Fonatsch C
Amplification of the AML1(CBFA2) gene on ring chromosomes in a patient with acute myeloid leukemia and a constitutional ring chromosome 21.
Cancer genetics and cytogenetics 2001;124(1):42-6.
2000: Schernthaner G H; Spanblöchl E; Sperr W R; Sillaber C; Semper H; Jurecka W; Hagen W; Wolff K; Chott A; Lechner K; Valent P
Effects of interferon-alpha2b treatment on ex vivo differentiation of mast cells from circulating progenitor cells in a patient with systemic mastocytosis.
Annals of hematology 2000;79(12):660-6.
2000: Flicker S; Vrtala S; Steinberger P; Vangelista L; Bufe A; Petersen A; Ghannadan M; Sperr W R; Valent P; Norderhaug L; Bohle B; Stockinger H; Suphioglu C; Ong E K; Kraft D; Valenta R
A human monoclonal IgE antibody defines a highly allergenic fragment of the major timothy grass pollen allergen, Phl p 5: molecular, immunological, and structural characterization of the epitope-containing domain.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(7):3849-59.
2000: Füreder W; Streubel B; Jordan J H; Walchshofer S; Wimazal F; Jäger U; Geissler K; Schwartz L B; Chott A; Lechner K; Valent P; Fonatsch C
Reciprocal translocation (3;5)(q26;q22) and possible BCHE gene involvement in an unusual myelogenous disorder with both myeloproliferative and dysplastic features.
Cancer genetics and cytogenetics 2000;121(2):133-8.
2000: Sperr W R; Natter S; Baghestanian M; Smolen J; Wolff K; Binder B R; Müller M R; Lechner K; Valenta R; Valent P
Autoantibody reactivity in a case of Schnitzler's syndrome: evidence for a Th1-like response and detection of IgG2 anti-FcepsilonRIalpha antibodies.
International archives of allergy and immunology 2000;122(4):279-86.
2000: Sperr W R; Horny H P; Lechner K; Valent P
Clinical and biologic diversity of leukemias occurring in patients with mastocytosis.
Leukemia & lymphoma 2000;37(5-6):473-86.
2000: Bugajska-Schretter A; Grote M; Vangelista L; Valent P; Sperr W R; Rumpold H; Pastore A; Reichelt R; Valenta R; Spitzauer S
Purification, biochemical, and immunological characterisation of a major food allergen: different immunoglobulin E recognition of the apo- and calcium-bound forms of carp parvalbumin.
Gut 2000;46(5):661-9.
2000: Streubel B; Valent P; Jäger U; Edelhäuser M; Wandt H; Wagner T; Büchner T; Lechner K; Fonatsch C
Amplification of the MLL gene on double minutes, a homogeneously staining region, and ring chromosomes in five patients with acute myeloid leukemia or myelodysplastic syndrome.
Genes, chromosomes & cancer 2000;27(4):380-6.
2000: Mahler V; Fischer S; Fuchs T; Ghannadan M; Valent P; Fartasch M; Kraft D; Schuler G; Valenta R
Prevention of latex allergy by selection of low-allergen gloves.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2000;30(4):509-20.
2000: Kiener H P; Hofbauer R; Tohidast-Akrad M; Walchshofer S; Redlich K; Bitzan P; Kapiotis S; Steiner G; Smolen J S; Valent P
Tumor necrosis factor alpha promotes the expression of stem cell factor in synovial fibroblasts and their capacity to induce mast cell chemotaxis.
Arthritis and rheumatism 2000;43(1):164-74.
1999: Füreder W; Weltermann A; Chott A; Gisslinger H; Valent P; Jäger U; Geissler K; Lechner K
Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine).
Wiener klinische Wochenschrift 1999;111(24):1027-30.
1999: Wimazal F; Ghannadan M; Müller M R; End A; Willheim M; Meidlinger P; Schernthaner G H; Jordan J H; Hagen W; Agis H; Sperr W R; Czerwenka K; Lechner K; Valent P
Expression of homing receptors and related molecules on human mast cells and basophils: a comparative analysis using multi-color flow cytometry and toluidine blue/immunofluorescence staining techniques.
Tissue antigens 1999;54(5):499-507.
1999: Vrtala S; Fischer S; Grote M; Vangelista L; Pastore A; Sperr W R; Valent P; Reichelt R; Kraft D; Valenta R
Molecular, immunological, and structural characterization of Phl p 6, a major allergen and P-particle-associated protein from Timothy grass (Phleum pratense) pollen.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(10):5489-96.
1999: Seiberler S; Bugajska-Schretter A; Hufnagl P; Binder B R; Stöckl J; Spitzauer S; Valent P; Valenta R
Characterization of IgE-reactive autoantigens in atopic dermatitis. 1. Subcellular distribution and tissue-specific expression.
International archives of allergy and immunology 1999;120(2):108-16.
1999: Bühring H J; Simmons P J; Pudney M; Müller R; Jarrossay D; van Agthoven A; Willheim M; Brugger W; Valent P; Kanz L
The monoclonal antibody 97A6 defines a novel surface antigen expressed on human basophils and their multipotent and unipotent progenitors.
Blood 1999;94(7):2343-56.
1999: Valent P; Escribano L; Parwaresch R M; Schemmel V; Schwartz L B; Sotlar K; Sperr W R; Horny H P
Recent advances in mastocytosis research. Summary of the Vienna Mastocytosis Meeting 1998.
International archives of allergy and immunology 1999;120(1):1-7.
1999: Streicher J; Valent P; Schmidt H; Sengölge G; Wagner O; Strobl W; Hörl W H; Derfler K
Up-regulation of LDL-receptor expression by LDL-immunoapheresis in patients with familial hypercholesterolemia.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 1999;47(8):378-87.
1999: Ball T; Fuchs T; Sperr W R; Valent P; Vangelista L; Kraft D; Valenta R
B cell epitopes of the major timothy grass pollen allergen, phl p 1, revealed by gene fragmentation as candidates for immunotherapy.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1999;13(11):1277-90.
1999: Agis H; Weltermann A; Mitterbauer G; Thalhammer R; Edelhäuser M; Seewann H L; Valent P; Lechner K; Fonatsch C; Geissler K
Successful treatment with arsenic trioxide of a patient with ATRA-resistant relapse of acute promyelocytic leukemia.
Annals of hematology 1999;78(7):329-32.
1999: Sillaber C; Walchshofer S; Mosberger I; Gaiger A; Simonitsch I; Chott A; Lechner K; Valent P
Immunophenotypic characterization of human bone marrow endosteal cells.
Tissue antigens 1999;53(6):559-68.
1999: Ball T; Sperr W R; Valent P; Lidholm J; Spitzauer S; Ebner C; Kraft D; Valenta R
Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy.
European journal of immunology 1999;29(6):2026-36.
1999: Vangelista L; Laffer S; Turek R; Grönlund H; Sperr W R; Valent P; Pastore A; Valenta R
The immunoglobulin-like modules Cepsilon3 and alpha2 are the minimal units necessary for human IgE-FcepsilonRI interaction.
The Journal of clinical investigation 1999;103(11):1571-8.
1999: Wimazal F; Sperr W R; Horny H P; Carroll V; Binder B R; Fonatsch C; Walchshofer S; Födinger M; Schwarzinger I; Samorapoompichit P; Chott A; Dvorak A M; Lechner K; Valent P
Hyperfibrinolysis in a case of myelodysplastic syndrome with leukemic spread of mast cells.
American journal of hematology 1999;61(1):66-77.
1999: Niederberger V; Hayek B; Vrtala S; Laffer S; Twardosz A; Vangelista L; Sperr W R; Valent P; Rumpold H; Kraft D; Ehrenberger K; Valenta R; Spitzauer S
Calcium-dependent immunoglobulin E recognition of the apo- and calcium-bound form of a cross-reactive two EF-hand timothy grass pollen allergen, Phl p 7.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1999;13(8):843-56.
1999: Vrtala S; Hirtenlehner K; Susani M; Hufnagl P; Binder B R; Vangelista L; Pastore A; Sperr W R; Valent P; Ebner C; Kraft D; Valenta R
Genetic engineering of recombinant hypoallergenic oligomers of the major birch pollen allergen, Bet v 1: candidates for specific immunotherapy.
International archives of allergy and immunology 1999;118(2-4):218-9.
1999: Laffer S; Hogbom E; Adrianson J; Grönlund H; Sillaber C; Valent P; Vangelista L; Kricek F; Kraft D; Valenta R
An in vitro model for the allergen-IgE-FcARI interaction.
International archives of allergy and immunology 1999;118(2-4):116-8.
1999: Bankl H C; Grossschmidt K; Pikula B; Bankl H; Lechner K; Valent P
Mast cells are augmented in deep vein thrombosis and express a profibrinolytic phenotype.
Human pathology 1999;30(2):188-94.
1999: Skyllouriotis P; Skyllouriotis-Lazarou M; Natter S; Steiner R; Spitzauer S; Kapiotis S; Valent P; Hirschl A M; Guber S E; Laufer G; Wollenek G; Wolner E; Wimmer M; Valenta R
IgG subclass reactivity to human cardiac myosin in cardiomyopathy patients is indicative of a Th1-like autoimmune disease.
Clinical and experimental immunology 1999;115(2):236-47.
1999: Sillaber C; Baghestanian M; Bevec D; Willheim M; Agis H; Kapiotis S; Füreder W; Bankl H C; Kiener H P; Speiser W; Binder B R; Lechner K; Valent P
The mast cell as site of tissue-type plasminogen activator expression and fibrinolysis.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(2):1032-41.
1998: Hayek B; Vangelista L; Pastore A; Sperr W R; Valent P; Vrtala S; Niederberger V; Twardosz A; Kraft D; Valenta R
Molecular and immunologic characterization of a highly cross-reactive two EF-hand calcium-binding alder pollen allergen, Aln g 4: structural basis for calcium-modulated IgE recognition.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(12):7031-9.
1998: Sperr W R; Walchshofer S; Horny H P; Födinger M; Simonitsch I; Fritsche-Polanz R; Schwarzinger I; Tschachler E; Sillaber C; Hagen W; Geissler K; Chott A; Lechner K; Valent P
Systemic mastocytosis associated with acute myeloid leukaemia: report of two cases and detection of the c-kit mutation Asp-816 to Val.
British journal of haematology 1998;103(3):740-9.
1998: Valenta R; Natter S; Seiberler S; Wichlas S; Maurer D; Hess M; Pavelka M; Grote M; Ferreira F; Szepfalusi Z; Valent P; Stingl G
Molecular characterization of an autoallergen, Hom s 1, identified by serum IgE from atopic dermatitis patients.
The Journal of investigative dermatology 1998;111(6):1178-83.
1998: Natter S; Seiberler S; Hufnagl P; Binder B R; Hirschl A M; Ring J; Abeck D; Schmidt T; Valent P; Valenta R
Isolation of cDNA clones coding for IgE autoantigens with serum IgE from atopic dermatitis patients.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1998;12(14):1559-69.
1998: Ghannadan M; Baghestanian M; Wimazal F; Eisenmenger M; Latal D; Kargül G; Walchshofer S; Sillaber C; Lechner K; Valent P
Phenotypic characterization of human skin mast cells by combined staining with toluidine blue and CD antibodies.
The Journal of investigative dermatology 1998;111(4):689-95.
1998: Schedle A; Rausch-Fan X H; Samorapoompichit P; Franz A; Leutmezer F; Spittler A; Baghestanian M; Lucas T; Valent P; Slavicek R; Boltz-Nitulescu G
Effects of dental amalgam and heavy metal cations on cytokine production by peripheral blood mononuclear cells in vitro.
Journal of biomedical materials research 1998;42(1):76-84.
1998: Virgolini I; Kurtaran A; Leimer M; Kaserer K; Peck-Radosavljevic M; Angelberger P; Hübsch P; Dvorak M; Valent P; Niederle B
Location of a VIPoma by iodine-123-vasoactive intestinal peptide scintigraphy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(9):1575-9.
1998: Horny H P; Sillaber C; Menke D; Kaiserling E; Wehrmann M; Stehberger B; Chott A; Lechner K; Lennert K; Valent P
Diagnostic value of immunostaining for tryptase in patients with mastocytosis.
The American journal of surgical pathology 1998;22(9):1132-40.
1998: Weltermann A; Pabinger I; Geissler K; Jäger U; Gisslinger H; Knöbl P; Eichinger S; Kyrle P A; Valent P; Speiser W; Schwarzinger I; Mannhalter C; Lechner K
Hypofibrinogenemia in non-M3 acute myeloid leukemia. Incidence, clinical and laboratory characteristics and prognosis.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1998;12(8):1182-6.
1998: Schedle A; Samorapoompichit P; Ghannadan M; Franz A; Sperr W R; Sperr W; Valent P
Effects of dental amalgam and its components of histamine release from human basophils and tissue mast cells.
Wiener klinische Wochenschrift 1998;110(13-14):467-72.
1998: Geissler K; Kabrna E; Stengg S; Schwarzinger I; Knöbl P; Valent P; Eichinger S; Barge A; Lechner K
Recombinant human megakaryocyte growth and development factor increases levels of circulating haemopoietic progenitor cells post chemotherapy in patients with acute myeloid leukaemia.
British journal of haematology 1998;102(2):535-43.
1998: Valenta R; Almo S; Ball T; Dolecek C; Steinberger P; Laffer S; Eibensteiner P; Flicker S; Vrtala S; Spitzauer S; Valent P; Denepoux S; Kraft D; Banchereau J; Lebecque S
The immunoglobulin E-allergen interaction: a target for therapy of type I allergic diseases.
International archives of allergy and immunology 1998;116(3):167-76.
1998: Vrtala S; Ball T; Spitzauer S; Pandjaitan B; Suphioglu C; Knox B; Sperr W R; Valent P; Kraft D; Valenta R
Immunization with purified natural and recombinant allergens induces mouse IgG1 antibodies that recognize similar epitopes as human IgE and inhibit the human IgE-allergen interaction and allergen-induced basophil degranulation.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(12):6137-44.
1998: Virgolini I; Leimer M; Handmaker H; Lastoria S; Bischof C; Muto P; Pangerl T; Gludovacz D; Peck-Radosavljevic M; Lister-James J; Hamilton G; Kaserer K; Valent P; Dean R
Somatostatin receptor subtype specificity and in vivo binding of a novel tumor tracer, 99mTc-P829.
Cancer research 1998;58(9):1850-9.
1998: Hagen W; Schwarzmeier J; Walchshofer S; Zojer N; Chott A; Sillaber C; Ackermann J; Simonitsch I; Bühring H J; Drach J; Lechner K; Horny H P; Valent P
A case of bone marrow mastocytosis associated with multiple myeloma.
Annals of hematology 1998;76(3-4):167-74.
1998: Schedle A; Samorapoompichit P; Füreder W; Rausch-Fan X H; Franz A; Sperr W R; Sperr W; Slavicek R; Simak S; Klepetko W; Ellinger A; Ghannadan M; Baghestanian M; Valent P
Metal ion-induced toxic histamine release from human basophils and mast cells.
Journal of biomedical materials research 1998;39(4):560-7.
1998: Wimazal F; Walchshofer S; Baghestanian M; Chott A; Sperr W R; Kopp C; Sillaber C; Semper H; Horny H P; Tröndle U; Födinger M; Schwarzinger I; Lechner K; Valent P
Detection of mi transcription factor (MITF) mRNA in a case of myelodysplastic syndrome and bone marrow mastocytosis.
Wiener klinische Wochenschrift 1998;110(3):79-88.
1998: Hirschwehr R; Heppner C; Spitzauer S; Sperr W R; Valent P; Berger U; Horak F; Jäger S; Kraft D; Valenta R
Identification of common allergenic structures in mugwort and ragweed pollen.
The Journal of allergy and clinical immunology 1998;101(2 Pt 1):196-206.
1998: Kiener H P; Baghestanian M; Dominkus M; Walchshofer S; Ghannadan M; Willheim M; Sillaber C; Graninger W B; Smolen J S; Valent P
Expression of the C5a receptor (CD88) on synovial mast cells in patients with rheumatoid arthritis.
Arthritis and rheumatism 1998;41(2):233-45.
1998: Beil W J; Füreder W; Wiener H; Grossschmidt K; Maier U; Schedle A; Bankl H C; Lechner K; Valent P
Phenotypic and functional characterization of mast cells derived from renal tumor tissues.
Experimental hematology 1998;26(2):158-69.
1998: Valent P; Sillaber C; Baghestanian M; Bankl H C; Kiener H P; Lechner K; Binder B R
What have mast cells to do with edema formation, the consecutive repair and fibrinolysis?
International archives of allergy and immunology 1998;115(1):2-8.
1997: Baghestanian M; Hofbauer R; Kiener H P; Bankl H C; Wimazal F; Willheim M; Scheiner O; Füreder W; Müller M R; Bevec D; Lechner K; Valent P
The c-kit ligand stem cell factor and anti-IgE promote expression of monocyte chemoattractant protein-1 in human lung mast cells.
Blood 1997;90(11):4438-49.
1997: Bankl H C; Radaszkiewicz T; Pikula B; Baghestanian M; Mehrabi M R; Bankl H; Lechner K; Valent P
Expression of fibrinolytic antigens in redistributed cardiac mast cells in auricular thrombosis.
Human pathology 1997;28(11):1283-90.
1997: Sperr W R; Agis H; Semper H; Valenta R; Susani M; Sperr M; Willheim M; Scheiner O; Liehl E; Lechner K; Valent P
Inhibition of allergen-induced histamine release from human basophils by cyclosporine A and FK-506.
International archives of allergy and immunology 1997;114(1):68-73.
1997: Virgolini I; Kurtaran A; Leimer M; Smith-Jones P; Agis H; Angelberger P; Kletter K; Valent P; Linkesch W; Eichler H G
Inhalation scintigraphy with iodine-123-labeled interferon gamma-1b: pulmonary deposition and dose escalation study in healthy volunteers.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(9):1475-81.
1997: Vrtala S; Hirtenlehner K; Vangelista L; Pastore A; Eichler H G; Sperr W R; Valent P; Ebner C; Kraft D; Valenta R
Division of the major birch pollen allergen, Bet v 1, into two non-anaphylactic fragments.
International archives of allergy and immunology 1997;113(1-3):246-8.
1997: Füreder W; Bankl H C; Toth J; Walchshofer S; Sperr W; Agis H; Semper H; Sillaber C; Lechner K; Valent P
Immunophenotypic and functional characterization of human tonsillar mast cells.
Journal of leukocyte biology 1997;61(5):592-9.
1997: Horny H P; Kaiserling E; Sillaber C; Walchshofer S; Valent P
Bone marrow mastocytosis associated with an undifferentiated extramedullary tumor of hemopoietic origin.
Archives of pathology & laboratory medicine 1997;121(4):423-6.
1997: Vrtala S; Hirtenlehner K; Vangelista L; Pastore A; Eichler H G; Sperr W R; Valent P; Ebner C; Kraft D; Valenta R
Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments: candidates for a novel form of specific immunotherapy.
The Journal of clinical investigation 1997;99(7):1673-81.
1997: Baghestanian M; Hofbauer R; Kress H G; Wojta J; Fabry A; Binder B R; Kaun C; Müller M R; Mehrabi M R; Kapiotis S; Sengoelge G; Ghannadan M; Lechner K; Valent P
Thrombin augments vascular cell-dependent migration of human mast cells: role of MGF.
Thrombosis and haemostasis 1997;77(3):577-84.
1997: Sillaber C; Baghestanian M; Hofbauer R; Virgolini I; Bankl H C; Füreder W; Agis H; Willheim M; Leimer M; Scheiner O; Binder B R; Kiener H P; Bevec D; Fritsch G; Majdic O; Kress H G; Gadner H; Lechner K; Valent P
Molecular and functional characterization of the urokinase receptor on human mast cells.
The Journal of biological chemistry 1997;272(12):7824-32.
1996: Baghestanian M; Agis H; Bevec D; Bankl H C; Hofbauer R; Kress H G; Butterfield J H; Müller M R; Ashman L K; Füreder W; Willheim M; Lechner K; Valent P
Stem cell factor-induced downregulation of c-kit in human lung mast cells and HMC-1 mast cells.
Experimental hematology 1996;24(12):1377-86.
1996: Virgolini I; Angelberger P; Li S; Yang Q; Kurtaran A; Raderer M; Neuhold N; Kaserer K; Leimer M; Peck-Radosavljevic M; Scheithauer W; Niederle B; Eichler H G; Valent P
In vitro and in vivo studies of three radiolabelled somatostatin analogues: 123I-octreotide (OCT), 123I-Tyr-3-OCT and 111In-DTPA-D-Phe-1-OCT.
European journal of nuclear medicine 1996;23(10):1388-99.
1996: Vrtala S; Wiedemann P; Mittermann I; Eichler H G; Sperr W R; Valent P; Kraft D; Valenta R
High-level expression in Escherichia coli and purification of recombinant plant profilins: comparison of IgE-binding capacity and allergenic activity.
Biochemical and biophysical research communications 1996;226(1):42-50.
1996: Virgolini I; Raderer M; Kurtaran A; Angelberger P; Yang Q; Radosavljevic M; Leimer M; Kaserer K; Li S R; Kornek G; Hübsch P; Niederle B; Pidlich J; Scheithauer W; Valent P
123I-vasoactive intestinal peptide (VIP) receptor scanning: update of imaging results in patients with adenocarcinomas and endocrine tumors of the gastrointestinal tract.
Nuclear medicine and biology 1996;23(6):685-92.
1996: Valenta R; Maurer D; Steiner R; Seiberler S; Sperr W R; Valent P; Spitzauer S; Kapiotis S; Smolen J; Stingl G
Immunoglobulin E response to human proteins in atopic patients.
The Journal of investigative dermatology 1996;107(2):203-8.
1996: Sperr W R; Agis H; Czerwenka K; Virgolini I; Bankl H C; Müller M R; Zsebo K; Lechner K; Valent P
Effects of cyclosporin A and FK-506 on stem cell factor-induced histamine secretion and growth of human mast cells.
The Journal of allergy and clinical immunology 1996;98(2):389-99.
1996: Agis H; Beil W J; Bankl H C; Füreder W; Sperr W R; Ghannadan M; Baghestanian M; Sillaber C; Bettelheim P; Lechner K; Valent P
Mast cell-lineage versus basophil lineage involvement in myeloproliferative and myelodysplastic syndromes: diagnostic role of cell-immunophenotyping.
Leukemia & lymphoma 1996;22(3-4):187-204.
1996: Agis H; Füreder W; Bankl H C; Kundi M; Sperr W R; Willheim M; Boltz-Nitulescu G; Butterfield J H; Kishi K; Lechner K; Valent P
Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes.
Immunology 1996;87(4):535-43.
1996: Vrtala S; Susani M; Sperr W R; Valent P; Laffer S; Dolecek C; Kraft D; Valenta R
Immunologic characterization of purified recombinant timothy grass pollen (Phleum pratense) allergens (Phl p 1, Phl p2, Phl p 5).
The Journal of allergy and clinical immunology 1996;97(3):781-7.
1996: Ferreira F D; Mayer P; Sperr W R; Valent P; Seiberler S; Ebner C; Liehl E; Scheiner O; Kraft D; Valenta R
Induction of IgE antibodies with predefined specificity in rhesus monkeys with recombinant birch pollen allergens, Bet v 1 and Bet v 2.
The Journal of allergy and clinical immunology 1996;97(1 Pt 1):95-103.
1996: Baghestanian M; Bankl H c; Sillaber C; Beil W J; Radaszkiewicz T; Füreder W; Preiser J; Vesely M; Schernthaner G; Lechner K; Valent P
A case of malignant mastocytosis with circulating mast cell precursors: biologic and phenotypic characterization of the malignant clone.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1996;10(1):159-66.
1996: Valenta R; Laffer S; Vrtala S; Grönlund H; Elfman L; Sperr W R; Valent P; Ferreira F; Mayer P; Liehl E; Heiss S; Steiner R; Eichler H G; Susani M; Kraft D
Recombinant allergens. Steps on the way to diagnosis and therapy of type I allergy.
Advances in experimental medicine and biology 1996;409():185-96.
1996: Valent P
Biology, classification and treatment of human mastocytosis.
Wiener klinische Wochenschrift 1996;108(13):385-97.
1996: Kapiotis S; Sengoelge G; Sperr W R; Baghestanian M; Quehenberger P; Bevec D; Li S R; Menzel E J; Mühl A; Zapolska D; Virgolini I; Valent P; Speiser W
Ibuprofen inhibits pyrogen-dependent expression of VCAM-1 and ICAM-1 on human endothelial cells.
Life sciences 1996;58(23):2167-81.
1995: Valent P
1995 Mack-Forster Award Lecture. Review. Mast cell differentiation antigens: expression in normal and malignant cells and use for diagnostic purposes.
European journal of clinical investigation 1995;25(10):715-20.
1995: Susani M; Jertschin P; Dolecek C; Sperr W R; Valent P; Ebner C; Kraft D; Valenta R; Scheiner O
High level expression of birch pollen profilin (Bet v 2) in Escherichia coli: purification and characterization of the recombinant allergen.
Biochemical and biophysical research communications 1995;215(1):250-63.
1995: Virgolini I; Kurtaran A; Raderer M; Leimer M; Angelberger P; Havlik E; Li S; Scheithauer W; Niederle B; Valent P
Vasoactive intestinal peptide receptor scintigraphy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(10):1732-9.
1995: Füreder W; Agis H; Willheim M; Bankl H C; Maier U; Kishi K; Müller M R; Czerwenka K; Radaszkiewicz T; Butterfield J H; Klappacher G W; Sperr W R; Oppermann M; Lechner K; Valent P
Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells.
Journal of immunology (Baltimore, Md. : 1950) 1995;155(6):3152-60.
1995: Valent P
Cytokines involved in growth and differentiation of human basophils and mast cells.
Experimental dermatology 1995;4(4 Pt 2):255-9.
1995: Schedle A; Samorapoompichit P; Rausch-Fan X H; Franz A; Füreder W; Sperr W R; Sperr W; Ellinger A; Slavicek R; Boltz-Nitulescu G; Valent P
Response of L-929 fibroblasts, human gingival fibroblasts, and human tissue mast cells to various metal cations.
Journal of dental research 1995;74(8):1513-20.
1995: Füreder W; Agis H; Semper H; Keil F; Maier U; Müller M R; Czerwenka K; Höfler H; Lechner K; Valent P
Differential response of human basophils and mast cells to recombinant chemokines.
Annals of hematology 1995;70(5):251-8.
1995: Willheim M; Agis H; Sperr W R; Köller M; Bankl H C; Kiener H; Fritsch G; Füreder W; Spittler A; Graninger W; Scheiner O; Gadner H; Lechner K; Boltz-Nitulescu G; Valent P
Purification of human basophils and mast cells by multistep separation technique and mAb to CDw17 and CD117/c-kit.
Journal of immunological methods 1995;182(1):115-29.
1995: Virgolini I; Li S R; Yang Q; Koller E; Sperr W R; Leimer M; Angelberger P; Nimpf J; Schneider W; Valent P
Characterization of LDL and VLDL binding sites on human basophils and mast cells.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(1):17-26.
1995: Bankl H C; Radaszkiewicz T; Klappacher G W; Glogar D; Sperr W R; Grossschmidt K; Bankl H; Lechner K; Valent P
Increase and redistribution of cardiac mast cells in auricular thrombosis. Possible role of kit ligand.
Circulation 1995;91(2):275-83.
1994: Valent P
The phenotype of human eosinophils, basophils, and mast cells.
The Journal of allergy and clinical immunology 1994;94(6 Pt 2):1177-83.
1994: Füreder W; Agis H; Sperr W R; Lechner K; Valent P
The surface membrane antigen phenotype of human blood basophils.
Allergy 1994;49(10):861-5.
1994: Valent P; Spanblöchl E; Bankl H C; Sperr W R; Marosi C; Pirc-Danoewinata H; Virgolini I; Eichler H G; Agis H; Sillaber C
Kit ligand/mast cell growth factor-independent differentiation of mast cells in myelodysplasia and chronic myeloid leukemic blast crisis.
Blood 1994;84(12):4322-32.
1994: Sperr W R; Bankl H C; Mundigler G; Klappacher G; Grossschmidt K; Agis H; Simon P; Laufer P; Imhof M; Radaszkiewicz T; Glogar D; Lechner K; Valent P
The human cardiac mast cell: localization, isolation, phenotype, and functional characterization.
Blood 1994;84(11):3876-84.
1994: Födinger M; Fritsch G; Winkler K; Emminger W; Mitterbauer G; Gadner H; Valent P; Mannhalter C
Origin of human mast cells: development from transplanted hematopoietic stem cells after allogeneic bone marrow transplantation.
Blood 1994;84(9):2954-9.
1994: Ball T; Vrtala S; Sperr W R; Valent P; Susani M; Kraft D; Valenta R
Isolation of an immunodominant IgE hapten from an epitope expression cDNA library. Dissection of the allergic effector reaction.
The Journal of biological chemistry 1994;269(45):28323-8.
1994: Sillaber C; Sperr W R; Agis H; Spanblöchl E; Lechner K; Valent P
Inhibition of stem cell factor dependent formation of human mast cells by interleukin-3 and interleukin-4.
International archives of allergy and immunology 1994;105(3):264-8.
1994: Virgolini I; Raderer M; Kurtaran A; Angelberger P; Banyai S; Yang Q; Li S; Banyai M; Pidlich J; Niederle B; Scheithauer W; Valent P
Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors.
The New England journal of medicine 1994;331(17):1116-21.
1994: Valent P
The riddle of the mast cell: kit(CD117)-ligand as the missing link?
Immunology today 1994;15(3):111-4.
1994: Spitzauer S; Schweiger C; Sperr W R; Pandjaitan B; Valent P; Mühl S; Ebner C; Scheiner O; Kraft D; Rumpold H
Molecular characterization of dog albumin as a cross-reactive allergen.
The Journal of allergy and clinical immunology 1994;93(3):614-27.
1994: Virgolini I; Yang Q; Li S; Angelberger P; Neuhold N; Niederle B; Scheithauer W; Valent P
Cross-competition between vasoactive intestinal peptide and somatostatin for binding to tumor cell membrane receptors.
Cancer research 1994;54(3):690-700.
1993: Vrtala S; Sperr W R; Reimitzer I; van Ree R; Laffer S; Müller W D; Valent P; Lechner K; Rumpold H; Kraft D
cDNA cloning of a major allergen from timothy grass (Phleum pratense) pollen; characterization of the recombinant Phl pV allergen.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(9):4773-81.
1993: Agis H; Willheim M; Sperr W R; Wilfing A; Krömer E; Kabrna E; Spanblöchl E; Strobl H; Geissler K; Spittler A; Boltz-Nitulescu G; Majdic O; Lechner K; Valent P
Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c-kit+, CD34+, Ly-, CD14-, CD17-, colony-forming cell.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(8):4221-7.
1993: Ferreira F D; Hoffmann-Sommergruber K; Breiteneder H; Pettenburger K; Ebner C; Sommergruber W; Steiner R; Bohle B; Sperr W R; Valent P
Purification and characterization of recombinant Bet v I, the major birch pollen allergen. Immunological equivalence to natural Bet v I.
The Journal of biological chemistry 1993;268(26):19574-80.
1993: Asano Y; Brach M A; Ahlers A; de Vos S; Butterfield J H; Ashman L K; Valent P; Gruss H J; Herrmann F
Phorbol ester 12-O-tetradecanoylphorbol-13-acetate down-regulates expression of the c-kit proto-oncogene product.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(5):2345-54.
1993: Sillaber C; Bevec D; Butterfield J H; Heppner C; Valenta R; Scheiner O; Kraft D; Lechner K; Bettelheim P; Valent P
Tumor necrosis factor alpha and interleukin-1 beta mRNA expression in HMC-1 cells: differential regulation of gene product expression by recombinant interleukin-4.
Experimental hematology 1993;21(9):1271-5.
1993: Valenta R; Sperr W R; Ferreira F; Valent P; Sillaber C; Tejkl M; Duchêne M; Ebner C; Lechner K; Kraft D
Induction of specific histamine release from basophils with purified natural and recombinant birch pollen allergens.
The Journal of allergy and clinical immunology 1993;91(1 Pt 1):88-97.
1993: Valent P; Sillaber C; Geissler K; Andreeff M; Tafuri A; Vieder L; Schulz G; Lechner K; Bettelheim P
Combination treatment of acute myeloblastic leukemia with rhGM-CSF and standard induction chemotherapy.
Cancer investigation 1993;11(2):229-34.
1993: Sperr W R; Czerwenka K; Mundigler G; Müller M R; Semper H; Klappacher G; Glogar H D; Lechner K; Valent P
Specific activation of human mast cells by the ligand for c-kit: comparison between lung, uterus and heart mast cells.
International archives of allergy and immunology 1993;102(2):170-5.
1993: Valenta R; Steinberger P; Vrtala S; Grote M; Laffer S; Sperr W R; Valent P; Kraft D; Scheiner O
[New concepts in therapy of type I allergic diseases]
Wiener klinische Wochenschrift 1993;105(23):682-6.
1992: Hirschwehr R; Valenta R; Ebner C; Ferreira F; Sperr W R; Valent P; Rohac M; Rumpold H; Scheiner O; Kraft D
Identification of common allergenic structures in hazel pollen and hazelnuts: a possible explanation for sensitivity to hazelnuts in patients allergic to tree pollen.
The Journal of allergy and clinical immunology 1992;90(6 Pt 1):927-36.
1992: Valent P; Spanblöchl E; Sperr W R; Sillaber C; Zsebo K M; Agis H; Strobl H; Geissler K; Bettelheim P; Lechner K
Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture.
Blood 1992;80(9):2237-45.
1992: Sillaber C; Geissler K; Scherrer R; Kaltenbrunner R; Bettelheim P; Lechner K; Valent P
Type beta transforming growth factors promote interleukin-3 (IL-3)-dependent differentiation of human basophils but inhibit IL-3-dependent differentiation of human eosinophils.
Blood 1992;80(3):634-41.
1992: Sperr W R; Agis H; Czerwenka K; Klepetko W; Kubista E; Boltz-Nitulescu G; Lechner K; Valent P
Differential expression of cell surface integrins on human mast cells and human basophils.
Annals of hematology 1992;65(1):10-6.
1992: Virgolini I; Li S; Sillaber C; Majdic O; Sinzinger H; Lechner K; Bettelheim P; Valent P
Characterization of prostaglandin (PG)-binding sites expressed on human basophils. Evidence for a prostaglandin E1, I2, and a D2 receptor.
The Journal of biological chemistry 1992;267(18):12700-8.
1992: Valent P; Sillaber K C; Scherrer R; Geissler K; Kier P; Kalhs P; Kundi M; Papoian R; Bettelheim P; Hinterberger W
Detection of circulating endogenous interleukin-3 in extensive chronic graft-versus-host disease.
Bone marrow transplantation 1992;9(5):331-6.
1992: Geissler K; Valent P; Bettelheim P; Sillaber C; Wagner B; Kyrle P; Hinterberger W; Lechner K; Liehl E; Mayer P
In vivo synergism of recombinant human interleukin-3 and recombinant human interleukin-6 on thrombopoiesis in primates.
Blood 1992;79(5):1155-60.
1992: Valenta R; Duchene M; Ebner C; Valent P; Sillaber C; Deviller P; Ferreira F; Tejkl M; Edelmann H; Kraft D
Profilins constitute a novel family of functional plant pan-allergens.
The Journal of experimental medicine 1992;175(2):377-85.
1992: Valent P; Bettelheim P
Cell surface structures on human basophils and mast cells: biochemical and functional characterization.
Advances in immunology 1992;52():333-423.
1992: Valent P; Sillaber C; Geissler K; Andreeff M; Tafuri A; Vieder L; Schulz G; Lechner K; Bettelheim P
Treatment of de novo acute myelogenous leukemia with recombinant granulocyte macrophage-colony-stimulating factor in combination with standard induction chemotherapy: effect of granulocyte macrophage-colony-stimulating factor on white blood cell counts.
Medical and pediatric oncology. Supplement 1992;2():18-22.
1991: Sillaber C; Strobl H; Bevec D; Ashman L K; Butterfield J H; Lechner K; Maurer D; Bettelheim P; Valent P
IL-4 regulates c-kit proto-oncogene product expression in human mast and myeloid progenitor cells.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(12):4224-8.
1991: Valenta R; Duchêne M; Pettenburger K; Sillaber C; Valent P; Bettelheim P; Breitenbach M; Rumpold H; Kraft D; Scheiner O
Identification of profilin as a novel pollen allergen; IgE autoreactivity in sensitized individuals.
Science (New York, N.Y.) 1991;253(5019):557-60.
1991: Kapiotis S; Besemer J; Bevec D; Valent P; Bettelheim P; Lechner K; Speiser W
Interleukin-4 counteracts pyrogen-induced downregulation of thrombomodulin in cultured human vascular endothelial cells.
Blood 1991;78(2):410-5.
1991: Pirker R; Wallner J; Geissler K; Linkesch W; Haas O A; Bettelheim P; Hopfner M; Scherrer R; Valent P; Havelec L
MDR1 gene expression and treatment outcome in acute myeloid leukemia.
Journal of the National Cancer Institute 1991;83(10):708-12.
1991: Volc-Platzer B; Valent P; Radaszkiewicz T; Mayer P; Bettelheim P; Wolff K
Recombinant human interleukin 3 induces proliferation of inflammatory cells and keratinocytes in vivo.
Laboratory investigation; a journal of technical methods and pathology 1991;64(4):557-66.
1991: Valent P; Bevec D; Maurer D; Besemer J; Di Padova F; Butterfield J H; Speiser W; Majdic O; Lechner K; Bettelheim P
Interleukin 4 promotes expression of mast cell ICAM-1 antigen.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(8):3339-42.
1991: Bettelheim P; Valent P; Andreeff M; Tafuri A; Haimi J; Gorischek C; Muhm M; Sillaber C; Haas O; Vieder L
Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in de novo acute myeloid leukemia.
Blood 1991;77(4):700-11.
1991: Fischer G F; Faé I; Valent P; Pickl W F
[The use of highly polymorphic DNA systems in the demonstration of mixed chimerism following bone marrow transplantation]
Wiener klinische Wochenschrift 1991;103(5):152-4.
1990: Valent P; Geissler K; Sillaber C; Lechner K; Bettelheim P
Why clinicians should be interested in interleukin-3.
Blut 1990;61(6):338-45.
1990: Valent P; Besemer J; Sillaber C; Butterfield J H; Eher R; Majdic O; Kishi K; Klepetko W; Eckersberger F; Lechner K
Failure to detect IL-3-binding sites on human mast cells.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(10):3432-7.
1990: Valent P; Besemer J; Kishi K; Di Padova F; Geissler K; Lechner K; Bettelheim P
Human basophils express interleukin-4 receptors.
Blood 1990;76(9):1734-8.
1990: Valent P; Besemer J; Kishi K; Kaltenbrunner R; Kuhn B; Maurer D; Lechner K; Bettelheim P
IL-3 promotes basophilic differentiation of KU812 cells through high affinity binding sites.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(6):1885-9.
1990: Bettelheim P; Muhm M; Valent P; Geissler K; Andreeff M; Haimi J; Sillaber C; Hinterberger W; Vieder L; Schulz G
GM-CSF in combination with cytotoxic chemotherapy in AML patients.
Bone marrow transplantation 1990;6 Suppl 1():127-30.
1990: Geissler K; Valent P; Mayer P; Liehl E; Hinterberger W; Lechner K; Bettelheim P
Recombinant human interleukin-3 expands the pool of circulating hematopoietic progenitor cells in primates--synergism with recombinant human granulocyte/macrophage colony-stimulating factor.
Blood 1990;75(12):2305-10.
1990: Stockinger H; Valent P; Majdic O; Bettelheim P; Knapp W
Human blood basophils synthesize interleukin-2 binding sites.
Blood 1990;75(9):1820-6.
1990: Schwarzinger I; Valent P; Köller U; Marosi C; Schneider B; Haas O; Knapp W; Lechner K; Bettelheim P
Prognostic significance of surface marker expression on blasts of patients with de novo acute myeloblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(3):423-30.
1990: Valent P; Bettelheim P
The human basophil.
Critical reviews in oncology/hematology 1990;10(4):327-52.
1990: Valent P; Majdic O; Maurer D; Bodger M; Muhm M; Bettelheim P
Further characterization of surface membrane structures expressed on human basophils and mast cells.
International archives of allergy and applied immunology 1990;91(2):198-203.
1989: Bettelheim P; Valent P
[Radioimmunometric determination of histamine in myeloproliferative syndromes]
Wiener klinische Wochenschrift 1989;101(20):706-10.
1989: Valent P; Besemer J; Muhm M; Majdic O; Lechner K; Bettelheim P
Interleukin 3 activates human blood basophils via high-affinity binding sites.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(14):5542-6.
1989: Valent P; Ashman L K; Hinterberger W; Eckersberger F; Majdic O; Lechner K; Bettelheim P
Mast cell typing: demonstration of a distinct hematopoietic cell type and evidence for immunophenotypic relationship to mononuclear phagocytes.
Blood 1989;73(7):1778-85.
1989: Valent P; Schmidt G; Besemer J; Mayer P; Zenke G; Liehl E; Hinterberger W; Lechner K; Maurer D; Bettelheim P
Interleukin-3 is a differentiation factor for human basophils.
Blood 1989;73(7):1763-9.
1988: Valent P; Bartram C R; Radaszkiewicz T; Hinterberger W; Lechner K; Bettelheim P
T cell receptor alpha mRNA transcription in T-lymphoblastic transformation of chronic myelocytic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1988;2(3):144-7.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Peter Valent

Research Profile (preview)

Anatomy

Chemicals & Drugs

Physiology

Disorders

Living Beings

Procedures

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Peter Valent (preview)

All Publications